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 Antitrypsin Deficiency is a primary cause of juvenile liver disease and arises from 
expression of the “Z” variant of the alpha-1 protease inhibitor (A1Pi). Whereas A1Pi is 
secreted from the liver, A1PiZ is retro-translocated from the endoplasmic reticulum (ER) 
and degraded by the proteasome, an event that may offset liver damage.  To better define 
the mechanism of A1PiZ degradation, a yeast expression system was developed and a gene, 
ADD66, was identified that facilitates A1PiZ turn-over (Palmer et al., J. Cell. Sci. 116, 
2361-2373, 2003).  I report here that ADD66 encodes an ~30 kDa soluble, cytosolic protein 
and that the chymotrypsin-like activity of the proteasome is reduced in add66Δ mutants.  
This reduction in activity may arise from the accumulation of 20S proteasome assembly 
intermediates or from qualitative differences in assembled proteasomes.  Add66p also 
appears to be a proteasome substrate.  Consistent with its role in ER associated 
degradation (ERAD), synthetic interactions are observed between the genes encoding 
Add66p and Ire1p, a transducer of the unfolded protein response, and yeast deleted for 
both ADD66 and/or IRE1 accumulate polyubiquitinated proteins.  These data identify 
Add66p as a proteasome assembly chaperone (PAC) and provide the first link between 
PAC activity and ERAD.  
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1.0  INTRODUCTION 
Cells undergo a constant flux between catabolism and anabolism.  The final homeostatic state is 
achieved due to the choreographed relations of various proteins within the cell, themselves 
regulated at multiple levels.  For example, the rates of protein synthesis or degradation must be 
precisely balanced, for even a subtle shift one way or another for prolonged periods of time will 
result in abnormal cell growth and/or cellular mass (Mitch and Goldberg, 1996).   
An old adage states that it is easier to destroy than to create, and while that may be true in 
society, the process of degradation within the cell is neither simple nor easy.  Protein degradation 
consists of a very complex set of steps that must be followed in a temporal and spatially defined 
manner.  In brief, proteins must be recognized as being a target for degradation, transported to 
the site of degradation, unfolded, and then finally broken down to the proteins’ basic 
components.  It is easy to imagine that each step in the protein degradation pathway can be 
further delineated into multiple regulatory steps.  You can then add the additional level of 
difficulty, in which the cell segregates select proteins into organelle structures, thus the 
degradation machinery must gain access to the select proteins.  Therefore, it is easier to 
appreciate the complex nature of protein degradation. 
The bulk of the work presented in this dissertation involves the role of one protein and its 
effect on the efficient assembly and maturation of the proteasome, a proteolytic machine that 
facilitates protein degradation within eukaryotic cells. 
1.1 UBIQUITIN PROTEASOME PATHWAY 
Unlike most regulatory mechanisms found within the eukaryotic cell, protein degradation is 
fundamentlly an irreversible step.  Thus, elimination of a protein or protein complex abolishes 
the protein’s function, and alters the cellular composition of proteins.  All intracellular proteins 
are consistently being turned over by hydrolysis into their constituent amino acids.  Therefore, 
the destruction of proteins allows efficient recycling of many proteins and the synthesis of new 
proteins.   
In eukaryotic cells, protein degradation can be broken down into four distinct pathways.  
The majority of proteins destined for degradation are eliminated by the ubiquitin (Ub) 
proteasome pathway (UPP) (Rock et al., 1994) and will be discussed in detail in this section.  In 
contrast, many extracellular and cell surface proteins are degraded by the yeast vacuoles or 
lysosomes in mammals.  These organelles contain proteases and hydrolyases in an acidic micro-
environment that promotes uninhibited degradation of the proteins translocated into these 
compartments (Glickman and Ciechanover, 2002; Nandi et al., 2006).  A third pathway results 
when some cytosolic proteins are degraded by the vacuole/lysosome during cellular stress 
conditions via the autophagic pathway (see below).  The fourth and final mechanism of protein 
degradation is the result of various cytosolic proteases, such as calpain or caspases.  These 
proteases are involved in programmed cell death during development of higher eukaryotes, 
activated during cell injury, and play a role during apoptosis (Salvesen and Dixit, 1997; Goll et 
al., 2003).   
The destruction of a target protein by the UPP requires two discrete and successive steps: 
[1] selection of the target protein by tagging the substrate through covalent attachment (see 
below) of multiple ubiquitin molecules, and [2] the degradation of the tagged protein by the 26S 
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proteasome with the subsequent release of reusable ubiquitin (Bochtler et al., 1999; Voges et al., 
1999; Glickman and Ciechanover, 2002; Soboleva and Baker, 2004; Nandi et al., 2006; Reed, 
2006). 
 The UPP begins with the choreographed actions of various enzymes that create a chain 
of polyubiquitin covalently attached to a substrate protein (Figure 1) (Kuhlbrodt et al., 2005; 
Asher et al., 2006; Hurley et al., 2006; Lecker et al., 2006; Reed, 2006; Xu and Peng, 2006).  
Polyubiquitination of substrates targets them for degradation by the 26S proteasome (described 
in detail below). Ubiquitin is a highly conserved 76 amino acid polypeptide that is abundant in 
all eukaryotic cells.  The initial step in the ubiquitination pathway is ATP-dependent and 
involves the linkage of ubiquitin to a ubiquitin-activating enzyme, or E1 enzyme, via a high 
energy thioester bond (Ciechanover et al., 1982).  Ubiquitin is then transferred via a second 
thioester linkage to a ubiquitin conjugating enzyme (Ubc), or E2 enzyme, which in turn catalyzes 
the covalent transfer of ubiquitin to the substrate protein.  The C-terminus of a glycine residue 
forms an isopeptide bond with a lysine residue in the substrate, though there have been reports of 
bond formation with cysteine residues or the N-terminal residue of the substrate (Ciechanover 
and Ben-Saadon, 2004; Cadwell and Coscoy, 2005).  In some cases, substrate polyubiquitination 
requires another enzyme, the ubiquitin ligase, or E3 enzyme.  The ubiquitin ligase can participate 
in the transfer of ubiquitin onto the substrate, or it can function as an adaptor to facilitate the 
positioning and transfer of ubiquitin from the E2 directly onto the substrate. A number of E3s 
have been shown to associate with select substrates (Jackson et al., 2000).  The consecutive 
addition of ubiquitin molecules to a substrate generates a polyubiquitin chain.  Both E2 and E3 
enzymes exist as large families and it is thought that different combinations of E2s with different 
E3 proteins define substrate specificity (Joazeiro and Weissman, 2000). For example, seventeen 
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E2s have been identified in the budding yeast, Saccharomyces cerevisiae, and many more exist 
in humans. In contrast to the E2s, whose catalytic sites are well conserved among species, only a 
few E3 ligases possess conserved and defined catalytic motifs (e.g., the HECT and RING 
domains) (Jackson et al., 2000).  Together, these few E2 and E3 enzymes, working in concert, 
can potentially target thousands of different protein substrates for proteasomal degradation. 
In the last decade, a ubiquitin elongation factor was identified and termed an  E4 (Hoppe, 
2005).  It was shown that efficient multiubiquitination was required for proteasomal targeting of 
the ubiquitin-fusion substrate.  The first E4 protein identified, Ufd2 (Ubiquitin Fusion 
Degradation pathway), is involved in proteasomal targeting of chimeric degradation substrates 
with a stable ubiquitin moiety fused to their N-termini (Johnson et al., 1995).  In yeast, E4 binds 
to the ubiquitin of short Ub conjugates and catalyzes ubiquitin chain elongation in conjunction 
with E1, E2, and E3 enzymes. It thus renders them preferred substrates for proteasomal 
degradation. 
1.1.1 The proteasome 
The rapid and selective degradation of proteins upon conjugation with polyubiquitin is catalyzed 
by the 26S proteasome (Bochtler et al., 1999; Gorbea et al., 1999; Voges et al., 1999; 
Heinemeyer et al., 2004; Asher et al., 2006; Nandi et al., 2006).  The 26S proteasome is an ~2.5 
MDa complex that is composed of approximately 60 different subunits whose function is to 
selectively degrade proteins into short amino acid peptide sequences.  There are two fundamental 
differences between the 26S proteasome and other proteases: [1] the 26S proteasome is 
dependent on ATP hydrolysis for protein degradation.  [2] The 26S proteasome progressively 
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Figure 1.  The ubiquitination pathway.   
The ubiquitination pathway is the result of three key steps: Activation of ubiquitin, 
transfer of ubiquitin, and ubiquitination.  Ubiquitin is activated in a two-step reaction by an E1 
ubiquitin-activating enzyme in a ATP dependent manner.   The initial step involves production 
of an ubiquitin-adenylate intermediate (not illustrated). The second step transfers ubiquitin to the 
E1 active site cysteine residue, with release of AMP. This results in a thioester linkage between 
the C-terminal carboxyl group of ubiquitin and the E1 cysteine sulfhydryl group.  The next step 
transfers ubiquitin from the E1 to the active site cysteine of a ubiquitin-conjugating enzyme E2 
via a trans(thio)esterification reaction. The final step of the ubiquitination cascade generally 
requires the activity of an E3 ubiquitin ligase, which functions as the substrate recognition 
receptor of the system and is capable of interacting with both the E2 and the substrate.  (Image 
obtained from http://en.wikipedia.org/wiki/Image:Ubiquitylation.png on 5/10/2007 with 
permission granted by Roger B. Dodd). 
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 Figure 1.  The ubiquitination pathway 
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 cleaves a polypeptide at multiple sites until the final peptide sequences, ranging from 3 to 25 
amino acid residues, are delivered from the particle, while a cytosolic protease may only cleave a 
substrate once or twice (Kisselev et al., 1999).   
The 26S proteasome is located in the cytoplasm, predominantly in a peri-nuclear sub-
cellular localization, and accounts for approximately 1% of the total cell mass (Peters et al., 
1994; Enenkel et al., 1998; Voges et al., 1999).  The 26S complex contains a central 20S 
proteolytic core particle (CP) and two 19S regulatory particles (Figure 2)  (Voges et al., 1999; 
Nandi et al., 2006).    The symmetrical, 20S barrel-shaped core particle of the proteasome is 
comprised of two half-proteasome complexes (15S) which result from two stacked hollow rings, 
per 15S complex,  of seven subunits per ring.  These half-proteasomes contain an outer ring of 
seven alpha subunits and an inner ring of seven beta subunits, in which three of the beta subunits 
are responsible for the CP’s proteolytic activity (Orlowski and Wilk, 2000).  The two outer alpha 
rings are identical to each other in composition and to the two inner beta rings also are identical 
in composition to each other.  The 20S core harbors three distinct proteolytic activities; a 
chymotrypsin-like (CTL), a trypsin-like (TL), and a peptidylglutamyl-peptide hydrolyzing 
(PGPH) activity (Voges et al., 1999; Heinemeyer et al., 2004). The beta subunits that are 
responsible for the proteolytic activity of the CP, belong to a family of hydrolases, designated as 
N-terminal nucleophilic (Ntn) hydrolases, and can hydrolyze amine bonds as well as peptide 
bonds (Bochtler et al., 1999).  These conserved beta subunits orient the region responsible for 
proteolytic activity towards the inner lumen of the CP, allowing efficient proteolysis of 
substrates within the CP.  Genes that encode Ntn hydrolases belong to a super-family of proteins 
and show great variability in protein structure as well proteolytic mechanisms.  However, the 
subunits  
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 Figure 2. The 26S proteasome.   
Composite model of the three-dimensional structure of the 26S proteasome from Drosophila 
based on electron microscopy and using the crystal structure of the 20S proteasome from 
Thermoplasma (Walz et al., 1998). The 19S cap (blue) attaches to one or both ends of the 20S 
core (yellow).  
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Figure 2. The 26S proteasome 
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responsible for proteolytic activity (Pre3p, Pre2p, and Pup1p) contain a conserved threonine 
(Thr1) and/or a conserved lysine (Lys33) residue that are required for proteolytic activity 
(Seemuller et al., 1995).   
Substrate entry into the 26S proteasome is gated by the 19S (also known as PA700) 
regulatory cap through a complex process.  The outer alpha rings of the CP create a narrow pore 
through which substrates enter and degradation products exit with the assistance of the 19S 
complex (Groll et al., 2000).  The 19S cap confines proteolysis within the 20S core and prevents 
nonspecific proteolysis of proteins in the cytoplasm.  The 19S particle contains polyubiquitin-
binding subunits, enzymes required for polypeptide de-ubiquitination, and six AAA ATPases 
(Glickman et al., 1998; Voges et al., 1999; Leggett et al., 2002; Verma et al., 2002; Guterman 
and Glickman, 2004; Soboleva and Baker, 2004).  These subunits are responsible for 
recognition, unfolding, de-ubiquitination, and translocation of the substrate into the lumen of the 
20S core.   
The 19S cap is made up of at least 19 different subunits and is conserved from yeast to 
mammals (Bochtler et al., 1999; Voges et al., 1999; Sharon et al., 2006).  This complex can be 
further divided into two sub-complexes, the base that binds directly to the 20S CP and the 
peripheral lid.  The base contains the AAA ATPases (Rpt1-Rpt6), as well as four non-ATPase 
subunits (Rpn1, Rpn2, Rpn10, Rpn13).  The ATPases are responsible for protein unfolding as 
well as CP channel opening (Glickman et al., 1998).  The lid is comprised of nine different non-
ATPase subunits (Rpn3, Rpn5-9, Rpn11, Rpn12, and Sem1).  The major activity of the lid is 
proposed to be de-ubiquitination (Yao and Cohen, 2002; Guterman and Glickman, 2004; 
Soboleva and Baker, 2004).  De-ubiquitinating enzymes (DUBs, Rpn11p is one example), which 
are thiol proteases, facilitate the recycling of Ub by cleaving ester, thiol ester, and amide bonds 
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which link Ub to amino acids (Yao and Cohen, 2002; Guterman and Glickman, 2004; Soboleva 
and Baker, 2004).  Rpn10p and Rpt5p have been shown to reversibly bind to ubiquitinated 
proteins and subsequently deliver them to the CP for degradation in an ATP dependent manner 
(Deveraux et al., 1994; Lam et al., 2002).  Thus, these various subunits, working in concert 
allow multi-ubiquitinated proteins to bind to the 19S cap, undergo de-ubiquitination, unfold, and 
be fed into the CP for proteolysis.  This exquisitely selective process allows only certain 
polypeptides to be degraded within the 26S proteasome.   
1.1.2 26S proteasome assembly and maturation  
The eukaryotic 26S proteasome serves as a vital final step in regulated protein degradation.  To 
ensure that this complex is present, a complex sequence of stages exists that allows the step-by-
step assembly and maturation of a proteolytic complex.    There are two distinct steps required 
for proteasome assembly: 20S core assembly and 19S assembly.   
While there have been significant strides to elucidate the mechanism for 20S core 
assembly over the last decade, the early steps in this process are still not clear.  At this time, a 
generalized theory of core assembly has been proposed, and is outlined in Figure 3 (Ramos et al., 
1998; Griffin et al., 2000; Witt et al., 2000; Tone and Toh, 2002; Heinemeyer et al., 2004; 
Hirano et al., 2006; Li et al., 2007).  In brief, alpha subunits assemble a ring structure which acts 
as a scaffold, and allows the beta subunits to combine and create a second stacked ring.   Thus, 
alpha ring formation provides the foundation for beta subunit ordering and orientation.  By 
expressing these subunits in bacteria, several groups have been able to recapitulate stages of 
alpha ring assembly in vitro from eukaryotic cells (Gerards et al., 1997; Gerards et al., 1998; 
Huang et al., 1999; Yao et al., 1999).  However, observations from these studies demonstrate  
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 Figure 3. 20S Proteasome assembly and maturation 
A model outlining the steps involved in proteasome assembly.  Seven free alpha subunits 
(yellow circles) form a ring structure and then associate with free beta subunits (red and green 
circles).  Subpopulations of beta subunits are proteolyticly inactive due to the retention of a pro-
peptide sequence.   The association of beta subunits with the alpha ring results in the formation 
of the half-proteasome.  The two half proteasomes dimerize and allow the pro-peptides to be 
cleaved, thus activating the 20S CP.  The approximate molecular mass of each intermediate is 
given. 
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that the alpha subunits do not contain all the information necessary for their correct positioning 
within the ring structure in vitro.  This suggests that alpha subunits either require other factors to 
properly assemble in the correct orientation or that the subsequent addition of beta subunits 
promotes reordering or replacement of alpha subunits to yield the final and complete ring 
structure.  Putative early structures in the proteasome assembly pathway, such as dimers or ring 
structures containing predominantly alpha subunits, appear to be short lived as they have yet to 
be completely identified and characterized.  
Once alpha ring formation has occurred, beta subunits associate with this structure to 
provide various intermediate complexes of different molecular masses and sizes (Frentzel et al., 
1994; Yang et al., 1995; Chen and Hochstrasser, 1996; Nandi et al., 1997; Ramos et al., 1998).  
One structure of note is the half proteasome of approximately 400 kDa in size that sediments at 
15S (Schmidtke et al., 1997).  The half proteasome consists of one ring of alpha and one ring of 
beta subunits.  Many of the beta subunits are considered unprocessed when they are components 
of the half proteasome, as a pro-peptide sequence in the N-terminal region is still present.  The 
pro-peptide sequence prevents proteolytic activity by masking the catalytic Thr1 in the Ntn 
hydrolases. However, some non-catalytic beta subunits also retain a pro-peptide sequence 
(Heinemeyer et al., 1997).  In the absence of pro-peptide cleavage, indiscriminate proteolysis in 
the cell by the various beta subunits is prevented.  Upon the dimerization of the two assembled 
half-proteasomes, proteolytic beta subunits undergo autocatalytic processing, resulting in the 
cleavage and subsequent removal of the pro-peptide sequence associated with the Ntn 
hydrolases.  Several beta subunits (Pre2p, Pre3p, Pre4p, and Pup1p) have been shown to be 
involved in subunit precursor processing and activating the 20S core complex (Heinemeyer et 
al., 1997). 
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In general, less is known about the assembly and maturation of the 19S regulatory 
particle. The regulatory particles are believed to assemble as two distinct subcomponents, the 
ATPase-containing base and the ubiquitin-recognizing lid (Deveraux et al., 1994). The six 
ATPases in the base may assemble in a pair-wise manner mediated by coiled-coil interactions 
(Gorbea et al., 1999). The order in which the nineteen subunits of the regulatory particle bind to 
each other may also prevent non-specific proteins becoming exposed to the 20S core active site 
before assembly is complete (Sharon et al., 2006). 
While the exact nature of proteasome assembly is not completely understood, it has 
become very evident in recent years that a class of proteins has emerged that facilitate the proper 
assembly and maturation of the 20S CP.  These proteins are termed proteasome assembly 
chaperones and are described in detail in the next section. 
1.1.3 Proteasome assembly chaperones (PACs) 
Work in the yeast Saccharomyces cerevisiae as well as in human cells over the past few years 
has established a series of dedicated proteasome assembly chaperones (PACs), which are 
proteins that facilitate and regulate proteasome assembly and maturation (Hirano et al., 2005).  
The first member of this class of proteins was identified in yeast and was termed “Underpins the 
Maturation of the Proteasome” or Ump1p (Ramos et al., 1998).  This protein was isolated in a 
screen that identified mutants involved in ubiquitin/proteasome degradation.  From this study, it 
was observed that yeast harboring the ump1 deletion mutation are viable but are sensitive to 
cellular stresses that lead to an accumulation of proteins destined for degradation (Ramos et al., 
1998).  Furthermore, deletion of UMP1 results in a reduction of all three proteolytic activities of 
the 26S proteasome.  Examination of beta subunits in the deletion strain revealed the retention of 
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the pro-peptide sequence and subsequently showed a drastic impairment of the proteolytic 
activity associated with the three beta subunits (Pre2p, Pre3p, and Pup1p).  Furthermore, Ump1p 
associates with the half proteasome, but not with the fully assembled CP or the 26S proteasome.  
Ump1p is also extremely short lived and is degraded upon proteasome maturation (Ramos et al., 
1998).  In fact, analysis of a defective CP strain, obtained by a point mutation in PRE1 which 
compromises the CP CTL activity, demonstrated stability of Ump1p as well as an association 
with the CP previously not seen.  This latter observation indicates that upon CP activation, 
Ump1p is degraded due to its association within the lumen of the CP (Ramos et al., 1998).  More 
recent work showed that Ump1p acts as a quality control checkpoint for half-proteasome 
dimerization (Li et al., 2007).  It is proposed that β7, believed to be the last subunit to associate 
with the partially assembled half-proteasome, associates with Ump1p, which was previously 
preventing pre-mature half proteasome dimerization.  Upon β7 and Ump1p association, the half 
proteasome undergos dimerization (Li et al., 2007).  Taken together, these studies indicate that 
Ump1p associates with CP subunits and early CP intermediates in order to facilitate the assembly 
and maturation of the proteasome.  Since the identification of Ump1p, other eukaryotic 
homologs, as well as a human homolog (Pomp1), have been isolated, and these homologs 
possess many of the same characteristics as Ump1p (Griffin et al., 2000; Witt et al., 2000). 
Subsequent to the discovery of Ump1p, a second protein was identified that facilitates the 
proper assembly of the 20S CP (Tone et al., 2000; Tone and Toh, 2002).  This second 
proteasome assembly chaperone, Nob1p, exhibited many of the same features as Ump1p.  Based 
on work performed by the Toh-e lab in Japan, Nob1p was hypothesized to play four major roles 
in proteasome function (Tone et al., 2000; Tone and Toh, 2002).  First, Nob1p associates with 
20S and 19S complexes the in nucleus.  This was demonstrated by Nob1p’s association with 
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Pno1p, an uncharacterized nuclear protein.  If either Nob1p or Pno1p was mutated, this led to an 
accumulation of proteasomes in the cytoplasm.  Second, Nob1p facilitates the maturation of the 
20S proteasome and degradation of Ump1p.   A genetic interaction between Nob1p and Ump1p 
was established.  Specifically, the over-expression of Nob1p complemented proteasome 
assembly defects observed in the ump1Δ mutant strains.  Also, the nob1-4 mutant strain 
exhibited defects in the processing of beta subunits and accumulated CP intermediates, similar to 
those observed in the UMP1 deletion strain.  Third, disruptions in NOB1 also resulted in a 
significant reduction in the chymotrypsin-like proteolytic activity of the 26S proteasome.  
Fourth, Nob1p resides within the lumen of the CP and is subsequently degraded by the 26S 
proteasome upon its activation.  Finally, it should be noted that no Nob1p orthologs have been 
identified in other eukaryotes.   
Studies conducted in mammalian cells have also isolated a few proteins that seem to be 
involved in proteasome assembly and maturation (Hirano et al., 2005; Hirano et al., 2006).  
Three particular proteins, PAC1, PAC2, and PAC3 have been shown to be required for the 
efficient assembly of mammalian 20S CP.  Unlike Ump1p or Nob1p, these proteins must 
dimerize to be active:  PAC 1 and PAC2 form a heterodimer while PAC3 forms a homodimer.  
The Murata lab demonstrated that over-expression of both PAC1 and PAC2 proteins accelerates 
proteasome assembly, while the induction of RNAi against either PAC1 or PAC2 resulted in an 
accumulation of immature 20S proteasomes (Hirano et al., 2005).  Furthermore, disruption of 
either PAC1 or PAC2 resulted in a reduction of the CTL activity of the 26S proteasome.  It was 
also established that PAC1 and PAC2 facilitate efficient alpha ring formation, which allows the 
rings to remain competent for half-proteasome formation.  Early studies in proteasome assembly 
demonstrated that expression of alpha subunits in vitro resulted in  ring structures with incorrect 
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alpha subunit positions (Gerards et al., 1997; Gerards et al., 1998; Huang et al., 1999; Yao et al., 
1999).  The Murata lab’s observations provide valuable insight into early CP assembly by 
suggesting these proteasome assembly chaperones regulate competent alpha ring formation.  
Finally, the PAC1 and PAC2 heterodimer disassociates from the 20S CP and subsequently is 
degraded by the proteasome (Hirano et al., 2006).  This observation differs from the Ump1p and 
Nob1p degradation pathways, as they are internalized during half proteasome dimerization and 
then degraded (Ramos et al., 1998; Tone and Toh, 2002).   
Until very recently, all previous work regarding PACs elucidated proteins that associate 
with early CP intermediates and which facilitate the assembly of and are finally degraded by the 
activated CP.  Recently published work shows the mammalian PAC3 homodimer also 
associating with early 20S intermediates, but then disassociates prior to half proteasome 
assembly (Hirano et al., 2006).  PAC3 seems to associate with both alpha and beta subunits and 
is required for alpha ring formation, but upon coupling with Pomp1, PAC3 disassociates from 
the complex.  This PAC3 disassociation occurs prior to half proteasome formation and prevents 
PAC3 degradation upon 20S CP activation.  This suggests that PAC3 may be recycled for future 
proteasome assembly processes.  All these observations together suggest that not all proteasome 
assembly chaperones behave in the same manner or at the same step in the proteasome assembly 
pathway.  Yet, interactions and cooperation between the various PACs seem to be required for 
proper assembly, since a triple PAC1/PAC2/PAC3 knockdown by RNAi resulted in an 
accumulation of incompetent half proteasome that were unable to properly dimerize (Hirano et 
al., 2006). 
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1.2 SECRETORY PATHWAY 
The proteasome functions as the final destination of a significant number of proteins, some of 
which have traveled through the secretory pathway.  The secretory pathway is a series of 
compartments a cell uses to move proteins out of the cell or deposit them in the ER, Golgi 
network, or vacuole/lysome (Figure 4).  The pathway is under high demand as approximately 
20% of all proteins reside in or traverse the secretory pathway, as determined by analysis of 
various eukaryotic genomes (Lander et al., 2001).  
The path of a protein destined for secretion begins in the rough endoplasmic reticulum 
(ER), a membrane bound compartment located within the cell that is continuous with the nuclear 
membrane (Johnson and van Waes, 1999).  Newly synthesized polypeptides are translocated into 
the ER.  Proteins can be imported into the ER either co-translationally or post-translationally.  
Co-translationally translocated proteins that enter into the ER contain a signal peptide that is 
recognized by the signal recognition particle (SRP) as the signal sequence emerges from the 
ribosome (Keenan et al., 2001).  The SRP, while associated with the ribosome and the newly 
synthesized polypeptide, binds to the SRP receptor located on the ER membrane.  At this point, 
the polypeptide is threaded into the Sec61 translocation channel which facilitates polypeptide 
entry into the ER.  Post-translationally translocated polypeptides disassociate completely from 
the ribosome and do not bind the SRP (Rapoport et al., 1999).  Regardless of the mode of import, 
entry into the ER is immediately followed by cleavage of the signal sequence (Jackson and 
Blobel, 1977). 
A major role of the ER is to post-translationally modify and package proteins destined for 
secretion or deposited along the secretory pathway (Gorlach et al., 2006).  Various alterations in 
the ER include glycosylation, disulfide bond formation, folding, and multi-protein complex  
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Figure 4.  Secretory pathway 
Co-translational translocation is depicted by ribosomes (grey circles) associated with 
mRNA (green line) which are then attached to the rough ER.  Newly synthesized polypeptides 
(red lines) are hereby referred to as the substrate.  As translation is started, the substrate is 
inserted into the lumen of the ER or into the membrane (not shown).  Molecular chaperones 
(blue lines), begin assisting the substrate in its folding through association or modifications of 
the substrate.  Grey lines illustrate the various resident proteins found in all compartments of the 
pathway.  The substrate is then translocated into the Cis-Medial-Trans Golgi network where 
further folding, modifications, and associations occur.  Finally, the substrate in its final 
conformation is transported to the plasma membrane and can be secreted.  The substrate may 
also be targeted to the vacuole or lysosome as its final destination or for degradation if a non-
native state is adopted and not reversed. 
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assembly.  Therefore, the lumen of the ER is a highly specialized compartment containing high 
levels of Ca2+ and ATP, as well as a high oxidation potential (Clairmont et al., 1992; Hwang et 
al., 1992; Michalak et al., 2002).  Furthermore, there is a high concentration of molecular 
chaperones (see below) that reside within the ER lumen and whose function is tailored to prevent 
improper folded states of nascent polypeptides.    
Molecular chaperones are a large and diverse group of proteins that associate with 
substrates non-covalently and facilitate the folding and unfolding of proteins as well as the 
assembly or disassembly of larger protein complexes (Brodsky et al., 1999; Fewell et al., 2001; 
Nishikawa et al., 2005).  Since molecular chaperones assist other proteins, they are not 
permanent components of their substrates.  Molecular chaperones were first characterized during 
nucleosome assembly in amphibians (Laskey et al., 1978), but have grown to include a diverse 
population of different proteins of various sizes.  These proteins are required in all cells to 
prevent and/or reverse improper conformations or associations of the chaperones’ substrates; 
which include proteins or RNAs (Cristofari and Darlix, 2002).  Chaperones may be classified 
into two categories, constitutively expressed (Hsc) or heat shock proteins (Hsp).  Constitutively 
expressed chaperones are considered house-keeping proteins that maintain the balance of protein 
synthesis during non-stressful conditions. On the other hand, heat shock proteins are induced 
during cellular stress since the requirement for chaperones increases, and these conditions cause 
proteins to misassemble or misfold at an increased rate. 
After folding in the ER and passing ER quality control (see below), secreted proteins are 
selectively incorporated into budding vesicles to be transported into the ER-Golgi intermediate 
compartment or the Golgi complex (Bonifacino and Glick, 2004).  These vesicles, which are 
coated with the COPII protein complex, collect the selected cargo from the ER and migrate to 
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the Golgi complex (Barlowe et al., 1994).   Proteins that are retained in the ER require retrograde 
transport back to the ER from the Golgi, which occurs via COPI coated vesicles and through the 
recognition of an ER retention signal  (Letourneur et al., 1994).  Protein substrates will then 
traffic along the Cis-Medial-Trans Golgi Network and can be transported to the plasma 
membrane, lysosome (or the vacuole in Fungi or plants).  Proteins can also be recycled within 
several compartments via components associated with the endocytic pathway (Clague, 1998). 
Regardless of their final destination, the cell employs a series of quality control check-
points at various stages along the secretory pathway.  These check-points help regulate protein 
traffic by ensuring that only properly maintained proteins or protein complexes may pass further 
along the pathway. One of the earliest check-points in the secretory pathway is ER protein 
quality control, which is discussed next. 
1.3 ENDOPLASMIC RETICULM PROTEIN QUALITY CONTROL 
There are quality control systems required at every step during DNA replication and RNA and 
protein synthesis, which prevents the accumulation of misfolded proteins within the cell.  In 
eukaryotic cells, it is estimated that approximately 25% of all newly synthesized secretory 
proteins misfold and are subsequently degraded (Schubert et al., 2000).  This accounts for only 
normal housekeeping quality control, and thus an increase in the production of mutant proteins 
greatly increases the rate of protein turnover immediately after biosynthesis (Lomas and Parfrey, 
2004).  As stated earlier, proteins that traverse the secretory pathway are translocated into the ER 
during or immediately after translation.  Upon entry to the ER, nascent proteins must fold and 
assemble into a mature state prior to being transported further along the pathway.  A mechanism 
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known as ER quality control (ERQC) monitors protein folding and assembly and prevents the 
transport of immature molecules (Ahner and Brodsky, 2004; Nishikawa et al., 2005; Sayeed and 
Ng, 2005).  Failure to achieve a competent state might subject the protein to degradation by the 
26S proteasome after removing the aberrant protein from the ER.  This process has been dubbed 
ER associated degradation, or ERAD.  ERAD eliminates the formation of possibly toxic or 
aggregation-prone substrates within the crowded ER. 
1.3.1 ER- associated degradation (ERAD)  
Soluble proteins that fail to pass quality control within the ER will be targeted for degradation by 
the 26S proteasome in a multi-step process referred to as ERAD (Cabral et al., 2002; McCracken 
and Brodsky, 2003; Ahner and Brodsky, 2004; Meusser et al., 2005; Nishikawa et al., 2005; 
Romisch, 2005; Sayeed and Ng, 2005).  Since all proteins entering the secretory pathway have 
the potential to become misfolded, ERAD must be able to identify a range of substrates from 
large and complex proteins such as the cystic fibrosis transmembrane regulator (CFTR) to 
relatively small soluble proteins like antitrypsin (A1Pi) (Coughlan and Brodsky, 2003, 2005).  
ERAD may be generalized into a five step process: selection of substrate, retrotranslocation, 
polyubiquitination of the substrate and transport to the proteasome, de-ubiquitination, and 
degradation by the proteasome (Figure 5).   
Recent evidence has suggested that while the proteasome is the final destination for all 
ERAD substrates, the requirements for the earlier steps differ for different substrates, particularly 
if the substrate is an ER lumenal protein or a transmembrane protein (Brodsky and McCracken, 
1999; Vashist et al., 2001; Vashist and Ng, 2004; Nishikawa et al., 2005).  Proteins with 
misfolded lumenal domains are monitored by ERAD- lumenal (ERAD-L) pathway components.  
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Figure 5.  ERAD pathway 
A model of the steps during the ERAD of a polypeptide (string of red circles).  First, the 
polypeptide is identified as a misfolded substrate by molecular chaperones (purple circle) (step 
1) and retrotranslocated from the ER into the cytoplasm through a putative pore in the ER 
membrane (step 2).  The misfolded substrate is then polyubiquitinated via the ubiquitin 
conjugating pathway (step 3) and transported to the 26S proteasome (blue/yellow 
macromolecule).  Substrate binding to the 19S regulatory cap (blue segment of 26S proteasome) 
results in substrate unfolding and de-ubiquitination (step 4).  Finally the substrate is degraded 
into small peptides by the 20S CP (yellow segment of the 26S proteasome) (step 5). 
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ERAD-L substrates seem to require ER to Golgi transport, the molecular chaperone BiP (see 
below), the transmembrane protein Der1p (see below), and Hrd1p, an E3 ubiquitin ligase.  The 
requirement for ER-to-Golgi transport suggests that ERAD-L substrates are sequestered to an 
exit site located within  the ER prior to degradation (Nishikawa et al., 1994).  In contrast, 
substrates with aberrant cytosolic domains fall under the ERAD-cytosolic (ERAD-C) pathway.  
ERAD-C substrates are not transported from the ER to the Golgi and do not utilize Hrd1p.  
Instead, Doa10p, another E3 ubiquitin ligase, is required. ERAD-C substrates also seem to be 
sequestered within a specialized sub-compartment of the ER prior to their degradation (Huyer et 
al., 2004).  It should be noted that both ERAD-L and ERAD-C substrate compartmentalization 
has only been examined for a limited number of substrates; thus these phenomena might not hold 
true for all ERAD substrates. 
Potential substrates for ERAD are recognized as being misfolded by molecular 
chaperones within the lumen of the ER (ERAD-L) or in the cytoplasm (ERAD-C).  The actual 
mechanism in which chaperones target a protein for entry into ERAD is not completely 
understood at this time, but this may be the result of a global defect in the structure of the protein 
instead of a particular altered residue.  In some instances prolonged association of some 
chaperones with an unfolded protein might select the substrate protein.  While at other times, 
different molecular chaperones that do not assist in proper folding and protein assembly might 
help target a substrate for ERAD (Zhang et al., 2001; Youker et al., 2004).  One protein that is 
required for post-translational and co-translational entry into the ER, protein folding, and the 
ERAD of many lumenal proteins, is the lumenal Hsp70, BiP (Kabani et al., 2003; Vashist and 
Ng, 2004).    The analysis of various BiP mutants has demonstrated discrete roles of this 
molecular chaperone during protein folding, sensing ER stress, and targeting proteins for 
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degradation (Mori et al., 1992; Brodsky et al., 1999; Zhang et al., 2001; Cabral et al., 2002; 
Kabani et al., 2003). 
Prior to retrotranslocation from the ER, a protein needs to be disassociated from any 
associated macromolecular complexes, such as those complexes with molecular chaperones, in 
order to remain in a soluble state (Nishikawa et al., 2001).  In recent years, the search for the 
putative pore complex responsible for retrotranslocation has led to the characterization of two 
different multi-transmembrane protein complexes that form pores (in the case of one complex) 
within the ER membrane that seem to be required for retrotranslocation (Romisch, 2005). The 
heterotrimeric Sec61 complex in mammals was first identified as associated with ERAD 
substrates prior to their degradation by the 26S proteasome (Wiertz et al., 1996).  In yeast, 
mutant sec61 alleles display reduced ERAD efficiency for various substrates as demonstrated by 
pulse chase analysis (Plemper et al., 1997).  But, these observations are difficult to intepet 
conclusively due to the pleiotropic effects of the mutant allele.  The second putative pore 
complex was identified in 2004, by the Ploegh and Rapoport labs, who concluded that Derlin-1 
associates with ERAD substrates during their extraction from the mammalian ER (Lilley and 
Ploegh, 2004; Ye et al., 2004).  Mutations in the yeast homolog of Derlin-1, Der1p, result in 
ERAD substrate stabilization (Knop et al., 1996).  Recently, Derlin-1, and not Sec61p, was 
shown to be required for the retrotranslocation of a derivative of the yeast mating pheromone 
pro-alpha-factor (Wahlman et al., 2007).  Due to the observation that Der1p is involved with the 
export of select ERAD substrates, while having little or no effect on other ERAD substrates, it is 
unlikely that there is only one major export pore within the ER. 
As discussed above, the ubiquitination of ERAD substrates is facilitated by the ER 
resident E3 ligases, Hrd1p and Doa10p (Hampton et al., 1996; Bays et al., 2001; Swanson et al., 
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2001).  Hrd1p as well as Doa10p both work in conjunction with the ubiquitin conjugating 
enzymes, Ubc6p and Ubc7p (Bays et al., 2001; Swanson et al., 2001).  It should be noted that the 
26S proteasome-mediated clipping of the transmembrane protein Ole1p is independent of both 
Hrd1p and Doa10p but relies on Ubc6p and Ubc7p (Braun et al., 2002).  These observations 
suggest that other E3 ligases may be involved with ubiquitination of ERAD substrates. 
After polyubiquitination, the substrate binds to the surface of the 19S cap of the 26S 
proteasome.  Rpn10p and Rpt5p, subunits of the 19S regulatory cap of the proteasome, recognize 
the proteolytic degradation signal, polyubiquitin, in an ATP dependent manner (Deveraux et al., 
1994; Lam et al., 2002).  Upon substrate association with the 19S cap, the protein unfolds and is 
de-ubiquitinated and finally translocated into the lumen of the 20S CP for degradation.   A 
subunit (Rpn11p) of the 19S regulatory cap of the 26S proteasome was identified as a 
metalloprotease responsible for the de-ubiquitinating enzymatic (DUB) activity prior to substrate 
degradation (Verma et al., 2002).  These observations for Rpt5p, Rpn10p and Rpn11p have 
provided evidence for the necessity of the 19S regulatory cap by coupling its roles in substrate 
recognition and de-ubiquitination prior to protein degradation.   
During the degradation of some substrates, it has been shown that de-ubiquitination is a 
rate-limiting process during proteasomal degradation (Yao and Cohen, 2002; Guterman and 
Glickman, 2004; Hanna et al., 2006).   However, some ERAD substrates, such as the mutant 
form of antitrypsin, can be degraded in both a ubiquitin-dependent and -independent manner 
(Teckman et al., 2000).   
Overall, it appears that each ERAD substrate requires different factors to promote the 
efficient degradation of the misfolded substrate (Fewell et al., 2001).  Although many of these 
factors are unknown, further examination of different ERAD substrates will provide further 
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insight into essential, redundant, and/or unique factors required for ERAD.   
1.3.2 Unfolded protein response (UPR) 
As stated earlier, approximately 25% of all secretory proteins that are newly synthesized may 
misfold and be subsequently degraded (Schubert et al., 2000).  This percentage represents only 
the basal levels of protein turnover and does not account for environmental or genetic stresses 
that might enhance protein miss-assembly and turnover within the cell.  While ERAD performs 
normal housekeeping degradation, the system can get overwhelmed in the presence of many 
misfolded proteins.  Thus, a second quality control mechanism is induced within the cell, known 
as the Unfolded Protein Response or UPR (Patil and Walter, 2001; Schroder and Kaufman, 
2005).  The UPR is an intracellular signaling pathway that transcriptionally up-regulates a 
specific population of genes whose role is to alleviate or eliminate the accumulation of unfolded 
proteins within the ER.   
The UPR signaling pathway responds to a variety of different stimuli.  For example, the 
UPR is induced by viral infection (Dimcheff et al., 2003).  Furthermore, the UPR is induced by 
nutrient or carbohydrate reduction and/or starvation (Schroder et al., 2000; Kuhn et al., 2001).  
Finally, the accumulation of various misfolded proteins within the ER induce the UPR (Mori et 
al., 1992; Shamu and Walter, 1996; Casagrande et al., 2000; Travers et al., 2000). 
No matter what conditions induce the UPR signaling pathway, it begins within the ER 
membrane, through the three domain transmembrane serine kinase, Ire1p (Figure 6) (Cox et al., 
1993; Shamu and Walter, 1996).  Association of two or more Ire1p molecules with an unfolded 
protein allows Ire1p dimerization and subsequent phosphorylation of the cytosolic kinase domain 
(Shamu and Walter, 1996; Welihinda and Kaufman, 1996).  This activates the cytosolic  
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 Figure 6.  UPR Pathway 
BiP, a molecular chaperone, is associated with Ire1p, a transmembrane protein kinase. It 
is unclear if this is a direct or indirect interaction (see text for details).  During non-stressful 
conditions, this BiP/Ire1p complex is maintained, which prevents the translation of HAC1 
mRNA, which encodes for a transcription factor.  During ER stress, BiP disassociates from 
Ire1p.  This allows Ire1p homodimerization and removal of the HAC1 mRNA intron which 
allows complete translation of the mRNA.  Hac1p then translocates into the nucleus and up-
regulates approximately 380 genes in yeast that help compensate for ER stress. 
 
 
 
 31 
 Figure 6. UPR pathway 
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endoribonuclease activity of Ire1p which cleaves an intron from a basic lucine zipper 
transcription factor Hac1p (Cox and Walter, 1996).  The removal of this classical intron allows 
HAC1 mRNA to be efficiently translated (Sidrauski and Walter, 1997).  Notably, removal of the 
HAC1 intron is not dependent on the spliceosome but only on Ire1p and is similar to tRNA 
splicing rather than mRNA splicing since a tRNA ligase is needed to repair the cleavage 
(Sidrauski et al., 1996).  Upon translation of Hac1p, the transcription factor is translocated into 
the nucleus and activates target gene transcription by binding a UPR specific upstream activating 
sequence, the unfolded protein response element (UPRE, see below) (Cox and Walter, 1996; 
Mori et al., 1996; Kawahara et al., 1997).   
The amino terminal domain of Ire1p resides in the ER lumen and recent structural 
examinations of this lumenal domain have created contradictory models for the mechanism of 
sensing unfolded proteins (Credle et al., 2005; Zhou et al., 2006).  Seminal work from the Kohno 
lab showed that BiP, a molecular chaperone, is tethered to Ire1p and upon accumulation of 
unfolded proteins within the ER, BiP dissociates from Ire1p to help fold substrates (Okamura et 
al., 2000).  This then lowers the level of the BiP-Ire1p complex, allowing Ire1p to homodimerize 
(Okamura et al., 2000; Zhou et al., 2006).  The Walters group disagrees with this model and 
suggests that Ire1p contains a groove in its lumenal domain which associates with unfolded 
proteins directly.  Ire1p dimerization is due to close association of Ire1p to a neighboring Ire1p 
along with a possible internal rearrangement of both Ire1ps when bound to an unfolded protein 
(Credle et al., 2005).   
The UPRE was originally defined as a 22-bp sequence that is involved in the up-
regulation of KAR2, the gene that encodes yeast BiP (Mori et al., 1992).  The 22-bp sequence has 
subsequently been reduced to an essential seven nucleotide E-box-like palindrome (CAGNGTG) 
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(Mori et al., 1998).  Furthermore, the UPRE has been identified in the promoter sequence for a 
variety of different UPR targets (Mori et al., 1998).  Mutations of the conserved sequence or the 
deletion of the central nucleotide result in reduced induction of UPR targets during times of ER 
stress (Mori et al., 1998).  Taken together, the specific sequence of the UPRE explains why only 
a discrete set of proteins are induced by the UPR to cope with ER stress. 
The target genes of the UPR encode factors that are involved in many different processes, 
such as phospholipid biosynthesis, protein maturation in the ER and secretory pathway function 
(Travers et al., 2000).  Yeast genomic microarray data indicate intimate interactions between 
ERAD and the UPR (Ng et al., 2000; Travers et al., 2000):  [1] Strains lacking nonessential 
genes required for ERAD lead to an induction of the UPR.  [2] Strains lacking ERAD required 
genes as well as IRE1 are inviable during heat stress.  [3] ERAD is less efficient in strains 
lacking Ire1p.  [4] Induction of the UPR increases the efficiency of ERAD.  Taken together, 
these observations indicate that cell viability is dependent on both ERAD and the UPR pathways 
and disruption of both will force cells to succumb to aberrant protein accumulation.   
Approximately 380 genes are induced during times of ER stress, and are thus putative 
targets of Hac1p (Travers et al., 2000).  However, initial examination of the promoter sequences 
in most of these genes failed to uncover a recognizable UPRE. However, computational analysis 
of upstream activating sequences (UAS) 5’ of UPR targets identified a second conserved 
sequence that is recognized by the Gcn4p transcription factor (Patil et al., 2004).  Gcn4p is up-
regulated during times of cellular stress by its activator Gcn2p.   Basal levels of Gcn4p are not 
sufficient to bind UPR targets, though its up-regulation during ER stress induces the UPR.  
Furthermore, dimerization with Hac1p facilitates the induction of many UPR targets.  These 
observations suggest that Gcn4p is a second UPRE-binding transcription factor that works in 
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parallel and/or downstream of Hac1p (Patil et al., 2004). 
1.4 AUTOPHAGY 
Eukaryotic cells have two complementary and conserved mechanisms to degrade proteins, the 
proteasome and the vacuole/lysosome.  The proteasome selectively degrades proteins that are 
misfolded, under metabolic regulation, a part of the major histocompatibility complex, or 
degraded for cell cycle progression (see above).  While the proteasome efficiently degrades 
soluble proteins, it may be limited in its ability to degrade aggregated proteins, membrane 
proteins, protein complexes, and even whole organelles.  To this end, the vacuole in yeast and 
plants or the lysosome in mammalian cells is designed to degrade larger and more complex 
substrates (Abeliovich and Klionsky, 2001; Huang and Klionsky, 2002; Noda et al., 2002).  
Autophagy is a membrane trafficking process that translocates bulk cytosoplasm and even entire 
organelles into the vacuole/lysosome during times of nutrient starvation or other physiological 
conditions (Clark, 1957; Ashford and Porter, 1962; Deter et al., 1967; Deter and De Duve, 
1967).  The vacuole/lysosome is a double membrane organelle that contains a plethora of 
hydrolases in a segregated compartment that forgoes the need for substrate selection upon entry 
into the organelle.  Entry into the vacuole/lysosome occurs through one of four different 
autophagic pathways: macroautophagy, the CVT pathway, microautophagy, and pexophagy 
(Figure 7).  For simplicity, the vacuole/lysosome will here by be referred to as the vacuole. 
Macroautophagy is often referred to as autophagy, and involves the de novo formation of 
a vesicle in the cytosol that sequesters cytoplasm and/or organelles which are then delivered to 
the vacuole (Noda et al., 2002).  One pre-vacuolar structure has been identified, the  
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 Figure 7.  Autophagy 
Macroautophagy and CVT vesicle formation begin with the preautophagosomal structure, 
PAS (green circle), which then engulfs cargo and transports it to the vacuole.  CVT pathway 
operates during vegetative conditions whereas macroautophagy is induced during nutrient 
starvation.  Pexophagy (micro and macro) regulates the number of peroxisomes within the cell.  
Macroautophagy, macropexophagy, and the CVT pathways all begin with vesicle formation 
independent of the vacuole, whereas microautophagy and micropexophagy occur directly at the 
vacuole or lysosome membrane.  Figure obtained from (Huang and Klionsky, 2002). 
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preautophagosomal structure (PAS), which contains various gene products that localize 
together transiently and catalyze vesicle formation  (Suzuki et al., 2001).  However, it is unclear 
how the PAS forms at this time.  The transport vesicle, or autophagosome, is a double membrane 
vesicle that is targeted to the vacuole by an unknown mechanism, and allows fusion of the outer 
membrane of the vesicle with the vacuole.  The interior membrane vesicle, or autophagic body, 
is then released into the lumen of the vacuole and its contents are degraded.  Autophagy requires 
a panoply of different proteins for vesicle formation, transport to the vacuole, and fusion of 
autophagosomes to the vacuole (partial list of autophagy factors located in Table 1 of Abeliovich 
and Klionsky, 2001).   
Macroautophagy is an inducible pathway that is up-regulated during times of nutrient 
stress or cell arrest.  The receptor that senses stress has been identified as the TOR (Target Of 
Rapamycin) receptor (Rohde et al., 2001).  TOR is a serine/theronine protein kinase that 
coordinates multiple cell responses due to nutrient conditions (Raught et al., 2001).  Through a 
signaling pathway involving a series of protein complexes, phosphorylation, and 
dephosphorylation, the result is the association of Atg13p and Atg1p, proteins required for 
macroautophagy initiation.  This association activates the Atg1p kinase function which is 
thought to in turn activate vesicle formation (Kamada et al., 2000).  Though, recent studies 
suggest that Atg1p may simply be required for macroautophagy (Abeliovich et al., 2003). 
While macroautophagy is an inducible catabolic pathway, a second conserved and 
constitutive pathway has been identified which operates similar to macroautophagy and is termed 
the cytoplasm-to-vacuole-targeting (CVT) pathway.  The majority of vacuolar hydrolases are 
transported to the vacuole via the secretory pathway due to the presence of specific vacuolar 
targeting sequences (Bryant and Stevens, 1998).  However, two vacuole hydrolases, Ams1p and 
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Ape1p, have been shown to be delivered to the vacuole independently of the secretory pathway 
(Yoshihisa and Anraku, 1990; Klionsky et al., 1992).  Ams1p and immature Ape1p (prApe1p) 
are encased in a densely compacted double membrane vesicle, called the CVT vesicle.  The 
overall process of Ams1p and prApe1p delivery to the vacuole is very similar to 
macroautophagy, but the process is not regulated by nutrient starvation.  It is interesting to note 
that CVT vesicles have been isolated inside autophagosomes in starved yeast (Baba et al., 1997).  
This suggests that the CVT pathway is co-opted by macroautophagy during times of ER stress 
and CVT vesicles are engulfed by autophagosomes. 
A third type of autophagy, which is not well defined, is microautophagy.  
Microautophagy is a process of invaginating a portion of the vacuole membrane to engulf 
neighboring cytoplasm and/or organelles (Yuan et al., 1997).  The fourth method of autophagy 
involves the degradation of peroxisomes, either by micro- or macropexophagy (Tuttle and Dunn, 
1995; Kim and Klionsky, 2000).   
1.5 PROTEIN CONFORMATIONAL DISEASES 
Over the past two decades a variety of human disorders have been identified and characterized 
due to our better understanding of how mutations affect synthesis, maturation, and regulation of 
specific proteins. Human disorders are classified into various groups; inflammatory, 
degenerative, infectious, neoplastic, or conformational.  Conformational disorders are the result 
of abnormal folding and subsequent aggregation of a particular protein (Carrell and Lomas, 
1997).  This is different than other genetic disorders, which result from a failure of protein 
production.  Proteins in this group are extremely diverse and are associated with a variety of 
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disorders: prion disorders such as encephalopathies, to neurodegenerative disorders like 
Huntington’s and Alzheimer’s disease, and the misfolded members of the serpin family protease 
inhibitors. The focus of this section is on one disorder, Antitrypsin Deficiency, which arises from 
a misfolded serpin. 
1.5.1 Antitrypsin Deficiency 
Alpha-1 Antitrypsin Deficiency (ATD) is a genetic disorder characterized by production of 
abnormal antitrypsin proteins (Carrell and Lomas, 1997, 2002; Parfrey et al., 2003; Lomas and 
Parfrey, 2004; Richmond and Zellner, 2005; Rudnick and Perlmutter, 2005).  Antitrypsin (AT) is 
a 53 kDa neutrophil inhibitor of pulmonary elastase that is induced during times of lung infection 
or due to lung irritation or injury (Myerowitz et al., 1972; Perlmutter, 2002).  Therefore, AT 
protects the tissue matrix of the pulmonary system from being damaged by proteolytic enzymes.  
AT is a serpin (short for serine protease inhibitor), which are a group of structurally related 
protein, that inhibit proteases (Law et al., 2006).  Most serpins, like antitrypsin, target trypsin-
like serine proteases, such as trypsin, which are characterized as having a serine residue in their 
catalytic site.  The structure of AT as well as over 80 other serpin family members have been 
solved and reveal the archetypical serpin fold (Figure 8). All serpins typically have three beta 
sheets and eight or nine alpha helices. Serpins also possess an exposed variable region termed the 
reactive central loop (RCL) that includes the specificity determining region and forms the initial 
interaction with the target protease.   The AT RCL loop contains key methionines and serines 
that act as bait for elastase and are essential for its inhibition (Carrell and Lomas, 2002).  
Inhibition is initiated when the RCL region is cleaved by the protease.  Elastase, which is then 
tethered to the RCL fragment, is flung to the other side of AT, which subsequently distorts the  
 40 
Figure 8.  2.0A structure of alpha-1 antitrypsin 
The X-ray crystal structure of native human antitrypsin is shown (protein database code 
1QLP).  The RCL variable loop has been annotated.  The image was obtained and modified from 
http://www.rcsb.org/pdb/explore.do?structureId=1QLP on May 16, 2007). 
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 RCL 
Figure 8. Antitrypsin structure 
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elastase structure and presents the protease for removal from tissue in a manner that is not fully 
understood (Janoff, 1985). 
 AT is secreted predominantly by hepatocytes, and significant reduction of secreted AT 
results in ATD (Carrell and Lomas, 2002; Perlmutter, 2002; Parfrey et al., 2003; Lomas and 
Parfrey, 2004; Richmond and Zellner, 2005; Rudnick and Perlmutter, 2005).  The rate of incident 
of the disorder is rather high in the Caucasian population in the United States with an estimate of 
1/3000 individuals affected.  In comparison, the genetic disorder cystic fibrosis has an 
occurrence of 1/2500 in the Caucasian population.   
Individuals afflicted with ATD present with low levels of secretion of an abnormal AT 
protein, which results in pulmonary tissue damage.  Chronic lung diseases, such as emphysema, 
asthma, and bronchitis, are the most common symptoms of ATD in adults and present as early as 
the second decade of life in humans (Colp et al., 1993; King et al., 1996; Eden et al., 1997; 
Rudnick and Perlmutter, 2005).  Those individuals that smoke present the disease at a much 
earlier age with an increased severity of symptoms (Larsson, 1978).  Specifically, when 
comparing normal individuals and ATD individuals, including if they smoked or did not smoke, 
there is a significant decrease in the level of forced expiratory volume per second for the ATD 
individuals, which is compounded if the same person smoked (Piitulainen and Eriksson, 1999).   
The accumulation of abnormal protein bodies within hepatocytes results in various forms 
of liver disease.   Liver diseases, such as cirrhosis of the liver, can result from ATD at any age 
and is the second most common reason for liver transplants in the United States.  The major risk 
factor for liver cirrhosis is  an increased level of aberrant AT polymers,  which normally occur in 
patients that maintain two copies of a genetically unstable allele of AT (Campra et al., 1973; 
Cruz et al., 1976; Mahadeva et al., 1999).  Abnormal AT retained in the liver dilates the ER and 
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large globules of aggregated AT are evident (Figure 9, see below).  This retention of abnormal 
AT results in widespread necrosis of hepatocytes and thus is known as a global liver disease.  
Although the exact mechanism is unknown, some ATD individuals (approximately 10%) 
present with various forms of hepatocellular carcinoma (Sveger, 1988).    Recent work from the 
Perlmutter lab suggests that AT globule-devoid cells are “sick but not dead” compared to 
hepatocytes that contain large globules of aggregated AT undergoing necrosis (Rudnick and 
Perlmutter, 2005).  This hypothesis has three implications: [1] these cells have activated a variety 
of stress response pathways, such as autophagy; [2] the cells are deficient in proliferation as well 
as growth; and [3] the globule containing cells are somehow inducing regenerative signals.  The 
reason that only some hepatocytes contain globules may be age, as younger liver cells may have 
insufficient time to accumulate abnormal AT to sufficient levels.  Also, the third implication 
suggests that the neighboring globule devoid cells would have a proliferation advantage 
compared to those globule containing cells.  This increased rate of proliferation could 
subsequently lead to an increase rate of liver carcinomas. 
There are currently four major treatment plans for those individuals with confirmed 
diagnosis of ATD (refer to http://www.alphaone.org/ for more information); behavioral and 
lifestyle modification, drug therapy for lung problems, specialized therapy for ATD, and surgical 
options.  [1] Behavioral and lifestyle modifications involve the cessation of smoking, avoidance 
of environmental pollutants, and implementation of an exercise program.  The ultimate goal of 
this treatment plan is to strengthen the lung capacity of an ATD patient.     [2] Drug therapy for 
lung problems includes vaccinations against influenza as well as medications for lung infections, 
thereby preventing further lung damage.  [3] ATD patients may undergo specialized therapy for 
ATD by receiving intravenous infusions of alpha-1 antitrypsin derived from donated human  
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Figure 9.  The accumulation of an aberrant form of antitrypsin in hepatocytes. 
A liver section from an ATD individual.  AT stains dark purple with an 
immunoperoxidase stain. Nuclei were stained blue with haematoxylin, and eosin stained the 
cytoplasm a light blue or lavender.  Image obtained from 
http://www.meddean.luc.edu/Lumen/MedEd/orfpath/cellch2.htm on May 16, 2007). 
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 Figure 9.  The accumulation of an aberrant form of antitrypsin in hepatocytes 
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plasma. This augmentation therapy is thought to arrest the course of the disease and halt any 
further damage to the lungs.  [4] ATD patients may undergo liver or lung transplants in cases of 
extreme damage to either organ. 
1.5.1.1 A1PiZ 
AT isolates were first defined by electrofocusing (isoelectric focusing) analysis, in which the 
protein underwent electrophoresis through a pH gradient (Myerowitz et al., 1972).  Normal wild 
type AT is termed "M", as it is neutral and does not migrate very far. Other variants, which are 
less active, are termed A-L and N-Z, dependent on whether they run more proximal or more 
distal to the M band. The presence of deviant bands by electrofocusing can signify the presence 
of ATD.  One allele of AT has been extensively studied and is linked to the most severe 
presentations of ATD; A1PiZ (or alpha-1 protease inhibitor, Z) (Lomas et al., 1992; Yu et al., 
1995).  Although secreted A1PiZ does retain partial activity, individuals expressing this protein 
have significantly lower circulating levels of the protein because the E342K mutation 
compromises its folding in the ER, rendering it a substrate for ERAD (Werner et al., 1996).  
However, when the A1PiZ variant accumulates, it can form loop-sheet polymers or aggregates 
that may trigger cirrhosis (Figure 9) (Foreman et al., 1984; Perlmutter et al., 1985; Mornex et al., 
1986; Verbanac and Heath, 1986; Brantly et al., 1988; McCracken et al., 1989; Lomas et al., 
1992; Mast et al., 1992; Kim et al., 1995; Sidhar et al., 1995; Carrell and Lomas, 2002; Parfrey 
et al., 2003) and hepatocellular carcinoma (Carlson et al., 1989; Rudnick and Perlmutter, 2005).  
Thus, A1PiZ is also a gain-of-function allele of ATD.  The loop sheet polymer formation of 
A1PiZ is due to aberrant alignment of the RCL due to steric interference of E342K, which results 
in a cleft at the top of the protein.  Thus, the RCL from one A1PiZ protein will then bind in the 
groove of a second A1PiZ protein, who’s RCL will then bind to a third A1PiZ protein, and so on, 
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until a loop-sheet polymer of A1PiZ aggregates are formed within hepatocytes. 
 Extensive studies of AT have been conducted over the years resulting in the elucidation 
of some of the processes by which both A1PiM as well as A1PiZ are secreted.  Unfortunately, 
the exact nature of how AT is expressed, processed, degraded, and secreted is unknown.  Also, 
due to the difficulty of manipulating and examining cultures from patients afflicted with ATD, 
the Brodsky and McCracken laboratories developed a yeast expression system to begin to 
address these questions (see below).   The results from the A1PiZ yeast expression system were 
valid for two reasons (McCracken and Kruse, 1993): [1] Components of the protein quality 
control machinery are highly conserved, and [2] yeast expression systems for several human 
disease-causing proteins have led to a better understanding of the pathological consequences of 
aberrant protein production (Coughlan and Brodsky, 2003).   
Notably, the A1PiZ yeast expression system helped establish this protein as a bona fide 
ERAD substrate (Werner et al., 1996).    Specifically, strains defective for the CTL activity of 
the proteasome degraded A1PiZ 3-times slower than wild type yeast strains (Figure 10).  
Furthermore, expression of wild type Pre1p and Pre2p in a pre-1-1 pre2-2 (proteasome mutant 
strain) strain complemented the A1PiZ degradation defect.  Later work identified BiP as an 
important player in A1PiZ turnover (Brodsky et al., 1999).  This result was subsequently 
confirmed in mammalian cells (Cabral et al., 2002; Schmidt and Perlmutter, 2005).   
The seminal work described above and more recent studies indicate that there are many 
possible fates for A1PiZ within the cell (Figure 11).  First, the AT gene product from cells 
containing the Z allele fails to properly mature and is not secreted from hepatocytes.  Therefore, 
the retained protein polymerizes to create large globules of aggregated protein that ultimately 
cause the cell to undergo apoptosis due to mitochondrial injury. 
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Figure 10.  The proteasome is required for the ERAD of A1PiZ. 
Pulse chase analysis of A1PiZ in the following yeast strains; pre1-1 pre2-2, pre1-1 pre2-
2 expressing Pre1p or Pre2p (pre1-1 pre2-2 + PRE1 or pre1-1 pre2-2 + PRE2), or an isogenic 
wild type.  (a) Mutations in the proteasome lead to an increase accumulation of A1PiZ in yeast.  
A representative phosphorimage of radiolabeled A1PiZ.  Immunoprecipitation products from 
samples taken at discrete time points (0, 60, 90, 120 mins) were treated (+) or not (-) with 
endoglycosidase H (EndoH) to remove carbohydrate chains that are added to A1PiZ within the 
ER.  (b)  Quantification of the degradation rates of A1PiZ in the above strains from three 
independent experiments.  Figure obtained from Werner et al. 1996.   
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 Figure 11.   The fate of A1PiZ. 
 Generalized model showing the possible fates of A1PiZ (red circles).  The aberrant 
protein is not secreted by the cell, and the retained A1PiZ can form loop-sheet polymer 
aggregates, or if soluble, can be degraded via ERAD.  However, the retained mutant protein will 
not induce the UPR.  The aggregated protein can also be degraded by the lysosome via the 
autophagic pathway.   
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(Van Molle et al., 1997; Teckman and Perlmutter, 2000; Perlmutter, 2002).  In addition, a 
portion of the aggregated protein is degraded by the lysosome via the autophagic pathway in 
mammals and in the vacuole of yeast (Teckman and Perlmutter, 2000; Kruse et al., 2006).  
However, it is not completely clear whether mitochondrial dysfunction is the result of the 
autophagic response to ER retention of A1PiZ or arises from the UPR, which is known to induce 
apoptosis when chronically stimulated (Wang and Ron, 1996; Nakagawa et al., 2000; Yoneda et 
al., 2001).  One can imagine that mitochondria are damaged nonspecifically by the autophagic 
response, which is activated to remove and subsequently degrade the aggregated mutant protein.  
But, the retention of this aberrant protein does not induce the UPR, even though A1PiZ is an 
ERAD substrate and soluble A1PiZ is degraded by the 26S proteasome in yeast and mammals 
(Qu et al., 1996; Werner et al., 1996).  Therefore, A1PiZ ERAD or autophagy may lead to 
apoptosis.  Overall, because of its unique attributes, it is likely that many proteins play a role in 
the removal of this mutant protein from the secretory pathway.  
1.5.2 Antitrypsin degradation deficient (ADD) Genes 
The Brodsky and McCracken laboratories wished to identify genes that affect the degradation of 
A1PiZ.  This was accomplished utilizing both a classical genetic approach (McCracken et al., 
1996) as well as a targeted approach (Palmer et al., 2003), and a class of genes termed 
antitrypsin degradation deficient (ADD) genes were identified.  While many of these ADD genes 
have not been characterized for their roles in A1PiZ degradation, some have allowed valuable 
insights into the complex nature of quality control within the secretory pathway.   
One of the genes isolated was ATG6/VPS30/ADD3, which is required for autophagy 
(Kametaka et al., 1998).  This gene was originally identified because of a slower degradation rate 
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of A1PiZ compared to wild type yeast strains (McCracken et al., 1996; Palmer et al., 2003).  
Mutations in this gene lead to compromised targeting of proteins to the vacuole via the 
autophagic pathway (Kruse et al., 2006).  Consistent with these data, yeast cells over-expressing 
A1PiZ, deliver the aggregated protein to the autophagic pathway (Kruse et al., 2006), and 
autophagic vesicles are abundant in liver biopsies from individuals with late-stage ATD 
(Teckman and Perlmutter, 2000).  In addition, A1PiZ-expressing autophagy-deficient cell lines 
degrade A1PiZ less efficiently than wild type cells (Kamimoto et al., 2006).  Taken together, this 
work demonstrates that A1PiZ degradation is linked to autophagy when expression levels are 
increased or the aberrant protein escapes ERAD. 
Given that a subset of the genes that are the ultimate targets of the unfolded protein 
response are also required for ERAD (Ng et al., 2000; Travers et al., 2000), the Brodsky and 
McCracken lab examined yeast strains deleted for the targets of the UPR to determine if these 
genes had an effect on the degradation of A1PiZ (Palmer et al., 2003).  This targeted approached 
examined approximately 70 non-essential and uncharacterized yeast genes which had robust 
induction via the UPR (Casagrande et al., 2000; Travers et al., 2000).  Utilizing a novel colony 
blot immunoassay screen, yeast strains lacking the gene of interest and expressing A1PiZ were 
examined and the level of A1PiZ accumulation was measured compared to wild type yeast 
strains (Palmer et al., 2003 and Section 2.2.5 for details).  A total of 6 add mutants were 
identified (Figure 12).  ADD66 was one of these six identified genes and its characterization is 
the focus of this dissertation. 
1.5.3 Antitrypsin degradation deficient 66 (ADD66) 
ADD66 (YKL206c) is predicted to encode a protein with a molecular mass of 30kDa.  The initial 
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Figure 12. Identification of ADD66 
A representative image of the colony blot immunoassay used to identify the ADD genes.  
In brief, yeast strains (1-73), deleted for the non-essential candidate genes and expressing A1PiZ 
were grown and spotted in duplicate on nitrocellulose paper and lysed in situ.  The filters were 
then probed for antitrypsin using a colorimetric detection assay to identify yeast genes that had 
elevated levels of A1PiZ.  The levels of A1PiZ accumulated in WT yeast strains expressing 
A1PiM (M), A1PiZ (Z), or containing an empty vector (O) were compared to the mutant yeast 
strains.  The add66Δ samples have been highlighted by a red oval.  Image obtained from Palmer 
et al., 2003. 
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analysis of ADD66 demonstrated that the deletion of the gene caused an accumulation of A1PiZ 
and slowed the rate of degradation of A1PiZ (Figure 12 and Figure 13A), but the ERAD of other 
substrates such as the mutated form of carboxypeptidase (CPY*) was not affected (Figure 13B) 
(Palmer et al., 2003).  CPY* is a soluble ERAD substrate which requires BiP for its efficient 
degradation (Plemper et al., 1997; Zhang et al., 2001).  The deletion of ADD66 modestly slowed 
the degradation of CFTR, but had no effect on the degradation of pro-alpha factor, a yeast 
pheromone and another ERAD substrate (Palmer et al., 2003).  This supports the view that each 
ERAD substrate requires a unique set of factors for their degradation (Fewell et al., 2001).   
As detailed above, ADD66 was a candidate for the colony blot assay because it is up-
regulated by the UPR (Casagrande et al., 2000; Travers et al., 2000).  Specifically, ADD66 
mRNA expression is increased 9.8 fold when cells were treated by tunicamycin, which inhibits 
N-linked glycosolation (Travers et al., 2000).  Furthermore, expression of mouse major 
histocompatability complex class I heavy chain (H-2Kb), a substrate for ERAD, led to a 2.5 fold 
increase of ADD66 mRNA in yeast (Casagrande et al., 2000).  These data indicate that ADD66 is 
a bona fide target of the UPR.   
 Global ERAD defects can lead to UPR induction due to the wide-spread accumulation of 
aberrant proteins within the ER (Fewell et al., 2001).  On the other hand, subtle or specific 
substrate ERAD defects might not be sufficient to induce a noticeable UPR.  Interestingly, 
deletion of ADD66 itself disrupted ER homeostasis in yeast significantly enough to cause a 3-
fold increase in the UPR when compared to the isogenic wild type strain (Palmer et al., 2003).  
Therefore, not only is ADD66 a target of the UPR, but Add66p plays a significant role in 
minimizing ER stress. 
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Figure 13.  Deletion of ADD66 exhibits differential effect on the degradation of two ERAD 
substrates. 
Pulse chase radiolabeling experiments were performed in the various add mutant strains 
characterized in Palmer, et al. 2003, and the results were compared to the isogenic wild type 
yeast strain.  For simplicity, ADD66 (blue) and add66Δ (red) are highlighted.  (A) A1PiZ was 
immunoprecipitated from cell extracts at 0, 20, 40, 60 minutes and resolved by SDS PAGE.  The 
relative amounts of A1PiZ were quantified and the amount of A1PiZ at 0 min was set to 100%.  
(B) CPY* was immunoprecipitated from cell extracts at 0, 20, 40, 60 minutes and resolved by 
SDS PAGE.  The relative amounts of CPY* were quantified and the amount of CPY* at 0 min 
set to 100%.  Results shown are the average of five independent experiments, +/- SD. 
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Overall, the initial studies of the putative functions of Add66p suggest that: [1] Add66p is 
required for the degradation of only a subset of ERAD substrates examined (Palmer et al., 2003).  
[2] ADD66 mRNA is induced by the UPR (Travers et al., 2000). [3] Yeast cells deleted for 
ADD66 induce the UPR (Palmer et al., 2003). Because of these observations, I suggested that 
Add66p might play a more general role in ER protein quality control.   
1.6 YEAST AS A MODEL ORGANISM 
The yeast species Saccharomyces cerevisiae, also known as baker’s or brewer’s yeast, has been 
used in baking bread and fermenting alcoholic beverages for millennia. In the last century, it has 
become extremely important as a model organism in modern cell biology research, and is one of 
the most thoroughly researched eukaryotic microorganisms to date. Researchers utilize yeast as a 
model organism to gather information on the biology of the eukaryotic cell and ultimately human 
biology (Ostergaard et al., 2000).  For the purpose of this dissertation, the use of the yeast system 
is possible since many aspects of protein synthesis, trafficking, and degradation are conserved 
between yeast and mammals.  Furthermore, S. cerevisiae was the first eukaryote to have its 
genome, consisting of 12 million base pairs and approximately 6,000 open reading frames 
sequenced (Williams, 1996).  In addition, yeast can perform homologous recombination, 
allowing researchers to isolate, delete, or manipulate individual genes.  Also, the budding yeast 
Saccharomyces cerevisiae offers a variety of genetic and biochemical tools enabling me to 
investigate the impact of protein regulation and degradation.   
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1.7 DISSERTATION OVERVIEW 
Proteasome assembly and maturation is complicated and requires a panoply of different proteins 
to form one of the largest multi-subunit complexes within the eukaryotic cell (Voges et al., 
1999).  This choreographed assembly would not be possible without the assistance of a class of 
proteins recently termed proteasome assembly factors (Heinemeyer et al., 1997; Ramos et al., 
1998; Tone and Toh, 2002; Hirano et al., 2005; Hirano et al., 2006; Li et al., 2007).  Only a few 
proteins have been identified as PACS in yeast and mammals (Yeast: Ump1p and Nob1p; 
Mammals: Pomp1, PAC1, PAC2, and PAC3).  While the recent identification of these PACs has 
provided some insights into the order of assembly and regulation of maturation, it is difficult to 
believe that these few PACs represent the complete list of proteasome assembly chaperones.   
In this work, I discuss the further characterization of the Add66p protein and determine 
its cellular function.  Specifically, I show that Add66p is a bona fide PAC and is required for 
maximal proteasome activity.  This work complements earlier studies on Add66p and explains 
why the deletion of ADD66 affects the clearance of some but not all ERAD substrates.  Finally, 
my examination of Add66p is strengthened by recently published work from the Hochstrasser 
lab that suggests that Add66p (named Pba2p by that group) is involved in early CP assembly (Li 
et al., 2007). 
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2.0  CHARACTERIZATION OF ADD66 AND ITS ROLE IN PROTEASOME 
ASSEMBLY AND MATURATION 
2.1 INTRODUCTION 
 
Newly synthesized secreted proteins must pass a stringent quality control check-point in the 
endoplasmic reticulum (ER), which ensures that only properly folded, assembled, and processed 
proteins transit the secretory pathway (Ellgaard and Helenius, 2003).  Polypeptides that fail to 
pass this check-point may be targeted for ER associated degradation (ERAD), a process in which 
aberrant proteins are selected and then delivered—or retro-translocated—to the cytoplasm and 
degraded by the 26S proteasome (Fewell et al., 2001; Tsai et al., 2002; Kostova and Wolf, 2003; 
Meusser et al., 2005; Romisch, 2005; Sayeed and Ng, 2005; Nandi et al., 2006).  The 26S 
proteasome is an ~2.5 MDa multi-subunit complex that contains a central 20S proteolytic core 
particle and two 19S regulatory particles (Voges et al., 1999; Nandi et al., 2006).  The 20S core 
harbors three distinct proteolytic activities—a chymotrypsin-like (CTL), a trypsin-like (TL), and 
a peptidylglutamyl-peptide hydrolyzing (PGPH) activity—whereas the 19S “cap” (also known as 
PA700) functions as a gate-keeper at the entrance of the core particle.  In addition, the 19S 
particle contains polyubiquitin-binding subunits, enzymes required for polypeptide de-
ubiquitination, and 6 AAA ATPases that are thought to unfold and feed polypeptides into the 
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core (Glickman et al., 1998; Voges et al., 1999; Leggett et al., 2002; Verma et al., 2002; 
Guterman and Glickman, 2004; Soboleva and Baker, 2004).   
Some ERAD substrates in humans are mutated versions of wild type proteins.  Not 
surprisingly, the absence of these functional proteins may lead to the onset of specific diseases 
(Aridor and Hannan, 2000, 2002; Coughlan and Brodsky, 2003).  One substrate in which the 
connection between ERAD and loss-of-function disease is quite clear is the Z-variant of alpha-1-
antitrypsin, also known as A1PiZ (or alpha-1 protease inhibitor, Z).  Wild type A1Pi, originally 
termed the “M” variant or A1PiM (Myerowitz et al., 1972), is an ~53 kDa serine protease 
inhibitor that is primarily synthesized in and secreted by hepatocytes (Perlmutter, 2002).  Serum 
A1Pi inhibits neutrophil proteases, which are released during inflammatory responses and can 
mediate proteolysis of the pulmonary connective tissue matrix (Richmond and Zellner, 2005; 
Rudnick and Perlmutter, 2005).  Although secreted A1PiZ retains partial activity, individuals 
expressing this protein have lower circulating levels of the protein because the E342K mutation 
compromises its folding in the ER.  The subsquent decrease in plasma levels of the protease 
inhibitor lead to antitrypsin deficiency (ATD), which is exemplified by uninhibited neutrophil 
elastase activity and destruction of the pulmonary extracellular matrix.  However, when the 
A1PiZ variant accumulates, it can form loop-sheet polymers or aggregates that may trigger 
cirrhosis (Foreman et al., 1984; Perlmutter et al., 1985; Mornex et al., 1986; Verbanac and 
Heath, 1986; Brantly et al., 1988; McCracken et al., 1989; Lomas et al., 1992; Mast et al., 1992; 
Kim et al., 1995; Sidhar et al., 1995; Carrell and Lomas, 2002; Parfrey et al., 2003) and 
hepatocellular carcinoma (Carlson et al., 1989; Rudnick and Perlmutter, 2005).  Thus, ATD is 
also a gain-of-function disease.   
Interestingly, only ~10% of A1PiZ-homozygotes develop liver disease (Sveger, 1988).  
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Although the reason for this remains a mystery, this phenomenon may arise because a subset of 
individuals is unable to efficiently clear this aggregation-prone molecule from the ER.  Indeed, 
A1PiZ-expressing fibroblasts from individuals with liver disease degrade the substrate less 
efficiently than A1PiZ-expressing fibroblasts from healthy homozygotes (Wu et al., 1994).  
Therefore, factors that alter the efficiency of A1PiZ ERAD may represent genetic modifiers of 
ATD. 
To identify putative ATD modifiers, the Brodsky and McCracken labs developed an 
A1PiZ yeast expression system (McCracken and Kruse, 1993) because: [1] Components of the 
protein quality control machinery are highly conserved, and [2] yeast expression systems for 
several human disease-causing proteins have led to a better understanding of the pathological 
consequences of aberrant protein production (Coughlan and Brodsky, 2003).  Notably, the 
A1PiZ yeast expression system helped establish this protein as a bona fide ERAD substrate 
(Werner et al., 1996) and identified an Hsp70 molecular chaperone in the lumen of the ER, 
known as BiP, as an important player in A1PiZ clearance (Brodsky et al., 1999).  This result was 
subsequently confirmed in mammalian cells (Cabral et al., 2002; Schmidt and Perlmutter, 2005).  
The Brodsky and McCracken labs also identified antitrypsin degradation deficient (ADD) 
mutants using both a classical genetic (McCracken et al., 1996) and a targeted approach (Palmer 
et al., 2003).  One of the genes isolated was ATG6/VPS30, which is required for autophagy 
(Kametaka et al., 1998), and yeast over-expressing A1PiZ deliver the aggregated protein to the 
autophagic pathway (Kruse et al., 2006).  Similarly, autophagic vesicles are abundant in liver 
biopsies from individuals with late-stage ATD (Teckman and Perlmutter, 2000) and A1PiZ-
expressing autophagy-deficient cell lines degrade A1PiZ less efficiently than wild type cells 
(Kamimoto et al., 2006).   
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Another yeast gene that was isolated is ADD66 (YKL206c).  Even though Add66p is 
required for the degradation of only a subset of ERAD substrates examined (Palmer et al., 2003), 
the ADD66 transcript is induced by the Unfold Protein Response (UPR) (Travers et al., 2000), 
which serves as an indicator of ER stress; moreover, the UPR and ERAD provide 
complementary mechanisms to lessen the effects of aberrant protein accumulation in the ER 
(Fewell et al., 2001; Patil and Walter, 2001; Schroder and Kaufman, 2005).  Because of these 
observations, and because cells deleted for ADD66 also induce the UPR (Palmer et al., 2003), I 
examined the hypothesis that Add66p might play a more general role in ER protein quality 
control.   
Here, I report that Add66p facilitates the maturation of the 20S proteasome particle, is 
vital for maximal proteasome activity, and like some other proteasome chaperones (Ramos et al., 
1998; Tone and Toh, 2002; Hirano et al., 2005) is a substrate for proteasome-mediated 
degradation.  Based on these results and on the sequence similarity between ADD66 and the 
mammalian proteasome assembly chaperone-2 (PAC2) (Hirano et al., 2005; Hirano et al., 2006), 
I propose that the S. cerevisiae Add66p and PAC2 share similar functions. Together, these 
results provide the first direct link between PAC activity and ERAD. 
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2.2 MATERIALS AND METHODS 
 
2.2.1 Strains and growth conditions 
The E. coli strain used in this study was DH5α (endA1 hsdR17 supE44 thi-1 recA1 gyrA relA1 Δ 
[lacZYA-argF] U169 deoR [Φ80 dlac Δ lacZ M15]). Bacteria were grown in Luria-Bertani (LB) 
medium supplemented with ampicillin (50 µg/ml) for plasmid selection. An add66Δ disruption 
cassette was obtained by amplifying pRS400 (Brachmann et al., 1998) with the following 
oligonucleotides: 5’ ACT TCA GGA AAG AAT AGC ACA AAA CCC AAA GGA ACA TAC 
GCT GTG CGG TAT TTC ACA CCG 3’ and 5’ ATA TAT GCA CTT GTA TAG AAA ACA 
GAT ATA CTT CTC GGT TAG ATT GTA CTG AGA GTG CAC.  ADD66 mutants were 
obtained as previously described (Brachmann et al., 1998).  A pdr5Δ haploid strain was isolated 
by sporulation and dissection of the yeast pdr5Δ homozygous diploid (Invitrogen).  All other 
yeast strains used in this study are detailed in Table 2 located in Appendix A and were grown on 
yeast extract-peptone (YP)-dextrose (YPD) medium or on synthetic complete (SC) medium 
lacking the indicated nutrient but supplemented with a carbohydrate source to a final 
concentration of 2% with or without the addition of the various indicated chemicals (Table 1).  
Yeast were grown at the indicated temperatures and all genetic and molecular manipulations 
followed standard published protocols (Adams et al., 1997). 
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2.2.2 Detection of polyubiquitinated proteins in yeast 
Yeast were transformed with a plasmid engineered for the expression of a ubiquitin-myc fusion 
protein under the transcriptional control of a copper inducible promoter ((Ecker et al., 1987); 
sub-cloned and provided by A. Caplan, Mount Sinai School of Medicine), and transformants 
were isolated on selective medium (SC-HIS) containing glucose.  A culture containing 20 ODs 
(optical density measured at 600 nm) of cells was grown to mid-log phase  (~1.0 OD per ml) at 
30°C before CuSO4 was added at a final concentration of 100 μM and the cells were incubated 
for 1 h.  The yeast were harvested and re-suspended in 100 μl of sample buffer (1.0% beta-
mercaptoethanol, 1% SDS, 5% glycerol, 0.05 mg/ml bromophenol blue, 65 mM Tris, pH 6.8), 
0.2 g of glass beads were added, and lystates were prepared by vigorous agitation on a Vortex 
mixer ten times for 1 min with a 1 min incubation in an ice bath between each treatment.  The 
total protein in a 5 μl aliquot of each sample was resolved by SDS-PAGE and transferred onto 
nitrocellulose blots.  The nitrocellulose was incubated for 30 min, while sandwiched in Whatman 
filter paper, in boiling double-distilled de-ionized water.  Ubiquitin and Sec61p, a component of 
the translocon that served as a loading control, were identified by western blotting using anti-myc 
(kindly provided by G. Apodaca and O. Weisz, University of Pittsburgh School of Medicine) and 
anti-Sec61p (Stirling et al., 1992).  Western blots were developed using Enhanced 
Chemiluminescence (Pierce) according to the manufacturer’s instructions.  Images were obtained 
on a Kodak 440CF Image Station and the results were quantified using Kodak 1D (version 3.6) 
imaging software. 
 
2.2.3 Expression of wild type and the Z variant of alpha-1-antitrypsin, PAC2, and 
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epitope-tagged Add66p  
Yeast were transformed with plasmids containing the genes encoding A1PiM or A1PiZ under the 
transcriptional control of a galactose inducible promoter (McCracken et al., 1996) and 
transformants were isolated on selective medium (SC-URA) containing glucose.  As a control, 
the indicated strains were also transformed with the pYES2 vector (Invitrogen) lacking an insert.  
To create an epitope-tagged version of Add66p, a single myc epitope was appended onto 
the C-terminus of Add66p by PCR amplification of genomic yeast DNA with the following 
oligonucleotides: 5’ CGC GGA TCC ATG AGC TGC CTG GTG TTG 3’ (to construct the 
pGPD vectors, see below) or 5’ CGC GGA TCC TCC TCG ATT TGA CTG GAA AC 3’ (to 
construct the pRS vector) and 5’ CCC AAG CTT TCA CAG GTC CTC CTC TGA GAT CAG 
CTT CTG CTC CTC ATT GTA TAA ATC TAC AAA TTT ATC TCT TGC 3’ (the underlined 
portion encodes the 11 amino acid myc epitope (Evan et al., 1985)).  The PCR fragment was 
inserted into the BamH1 and ClaI sites in the pPRS315, pGPD425, and pGPD426 vectors 
(Sikorski and Hieter, 1989; Mumberg et al., 1995) and the in-frame insertion and integrity of 
ADD66 were confirmed by DNA sequence analysis.  The corresponding vectors or the vectors 
lacking an insert were introduced into the indicated strains and transformants were isolated on 
selective media.  Next, yeast were grown to mid-log phase, 2.0 ODs of cells were harvested, and 
total cell extracts were prepared as previously published (Brodsky et al., 1998).  Add66p-myc 
expression was assessed after SDS-PAGE by western blotting, as described above, using anti-
serum against myc. 
To create a mammalian PAC2 expression vector, I obtained PAC2 cDNA maintained in a 
Bluescript expression vector (Stratagene) which was received from Dr. Jiyang O-Wang (Riken 
Yokohama Institute, Japan).  The PAC2 cDNA is similar to the one reported previously, but with 
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a shortened 5’ UTR (Bahar et al., 2002).  The PAC2 cDNA insert was excised from the 
Bluescript vector and inserted at the same sites into a pcDNA 3.0 (Invitrogen) vector at the Xho1 
and EcoR1 restriction sites.  The in-frame insertion and integrity of ADD66 were confirmed by 
DNA sequence analysis. 
 
2.2.4 A yeast colony blot assay for A1PiZ accumulation  
A colony blot immunoassay was performed to assess A1PiZ levels in wild type and select mutant 
yeast as previously described (Palmer et al., 2003).  In brief, 3 μl (0.001 OD) of cells from a 
saturated culture were spotted onto nitrocellulose that had been overlaid onto selective medium 
containing 2% galactose to induce expression of A1PiZ.  After a 36 h incubation at 35°C, the 
cells were lysed.  A1Pi was detected by immunoblotting and the results were quantified using the 
Molecular Analyst program (Bio-Rad).  The signals corresponded to cell and protein levels in the 
linear range of detection.  Previous work established the validity of using the colony blotting 
protocol as a means to report on AiPiZ turn-over in wild type and the add66Δ mutant (Palmer et 
al., 2003). 
 
2.2.5 Add66p localization 
The residence of Add66p-myc was assessed by biochemical fractionation using a previously 
published method, with minor modifications (Kabani et al., 2002).  Specifically, detection of 
Add66p-myc by western blotting required 1000 ODs of mid-log phase yeast that contained the 
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pGPD425-Add66p-myc expression vector and that had been grown at 30°C.   
To assess Add66p-myc localization by indirect immunofluorescence (IF) microscopy, a 
previously described protocol was used (Coughlan et al., 2004) employing yeast containing 
either the Add66p-myc expression vector under the transcriptional control of a constitutive 
promoter (pGPD) or the vector lacking an insert (as a negative control).  Images were captured 
on an Olympus BX60 microscope fitted with a Hamamatsu C4742-95 digital camera and were 
analyzed using QED Imaging software (Pittsburgh, PA). 
 
2.2.6 Purification of yeast 26S proteasomes 
FLAG-tagged 26S proteasomes were purified from RJD1144 as described (Verma et al., 2000; 
Saeki et al., 2005; Verma and Deshaies, 2005) with minor modifications.  In brief, cells were 
grown to an OD of ~3, frozen in liquid nitrogen and ground in a Waring blender.  The ground 
powder (~20 ml) was thawed with 9 ml of lysis buffer (50 mM Tris pH 7.5, 150 mM NaCl, 10% 
glycerol, 5 mM MgCl2) plus 5 mM ATP, 2x ATP regenerating system (0.02 mg/ml creatine 
phophokinase, 20 mM creatine phosphate), 5 mM MgCl2 and 1 mM DTT.  After centrifugation 
at 15,000 rpm for 20 min at 4˚C in a Sorvall SS34 rotor, the supernatant (~13 ml) was 
supplemented with 5 mM ATP, 2x ATP regenerating system and 5 mM MgCl2, and incubated 
with 300 µl of 50% (v/v) washed FLAG agarose beads (Sigma) at 4˚C for 1.5 h with rocking.  
The agarose beads were washed twice with 10 ml of lysis buffer plus 2 mM ATP and 1 mM 
DTT, once with 5 ml of lysis buffer plus 2 mM ATP, 1 mM DTT and 0.2% TritonX-100, once 
with 5 ml of lysis buffer plus 2 mM ATP and 1 mM DTT, once with 800 µl of lysis buffer plus 2 
mM ATP and 1 mM DTT, and once with 1 ml of 26S elution buffer (25 mM Tris pH 7.5, 10 mM 
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MgCl2, 150 mM NaCl, 15% glycerol) plus 2 mM ATP.  The bound proteins were eluted with 
400 µl of 26S elution buffer plus 2 mM ATP supplemented with 1/50 volume of 5 mg/ml 
3xFLAG peptide (DYKDDDDK (Biotechnology Center, University of Pittsburgh)) by 
incubating for 3 h at 4˚C with rocking.  The eluted proteasomes were enriched to ~0.9 mg/ml 
using a Centricon-30 micro-concentrator and stored at -80°C. 
 
2.2.7 Proteasome activity assays and glycerol gradient analysis 
Proteasome activity was assessed in clarified yeast cytosols that were obtained from 2 l of the 
indicated strains grown in selective medium to mid-log phase at 30 °C.  The cell pellet was 
washed with water and re-suspended in 500 μl of Buffer 88 (20 mM HEPES pH 6.8, 150 mM 
KOAc, 5 mM MgOAc, 250 mM sorbitol), and the cell-slurry was frozen in liquid nitrogen.  
Frozen cells were lysed by grinding with a mortar-and-pestle in the presence of liquid nitrogen 
for 12 min and the cells were thawed in the presence of a minimal amount of Buffer 88 
containing 1 mM DTT.  Unbroken cells and debris were removed by centrifugation in a Sorvall 
SS34 rotor at 9,000xg for 10 min at 4 °C, and the supernatant was clarified by centrifugation at 
300,000xg for 1 h at 4 °C.  The clarified cytosol was then aliquoted and snap-frozen in liquid 
nitrogen and stored at -80 °C.  Total protein was quantified using the Bio-Rad protein assay kit 
with bovine serum albumin (BSA) as a standard. 
Proteasome activity was determined by modifying a previously described protocol 
(Glickman et al., 1998).  First, a total of 100 μg of clarified cytosol was diluted into 1.8 ml of 
Buffer A (50 mM Tris-HCl pH 7.4, 5 mM MgCl2, 10% glycerol, 1 mM ATP, 1 mM DTT) and 
incubated on ice for 30 min in either the presence or absence of 100 μM MG-132 or leupeptin.  
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Next, a fluorescent substrate to detect each proteasome activity (CTL:  Suc-LLVY-AMC 
[Sigma], TL: Cbz-AAR-AMC [Cal BioChem], PGPH:  Cbz-LLE-AMC [Cal BioChem]) was 
added to a final concentration of 100 μM and the reactions were shifted to 30°C for the indicated 
time points and quenched by the addition of 1% SDS (final concentration).  Where noted, a total 
of 0.5 μg of purified 26S proteasomes were utilized and treated identically.  Fluorescence was 
determined on an Aminco-Bowman Series 2 Luminescence Spectrometer (excitation: 380 nm; 
emission: 436 nm).   The CTL, TL, and PGPH activities were confirmed using the following 
inhibitors at a final concentration of 100 μM: MG-132 (for CTL and PGPH) and leupeptin (for 
TL) (Savory and Rivett, 1993; Gaczynska and Osmulski, 2005).  The activity in each reaction 
and at each time point was obtained after the background fluorescence in the presence of each 
inhibitor was subtracted from the net fluorescence.  When extracts were examined, the data were 
then normalized to the activities observed in lysates from the reaction containing 400 μg of 
cytosol (Figure 18) or 100 μg (Figure 19) of the respective isogenic wild type strains at reaction 
times of 10 min for the CTL activity, and at 60 min for the TL and PGPH activities.  When 
highly enriched proteasomes were examined, the data were normalized to the activities observed 
in the absence of inhibitors at 180 min (Figure 19, third column), and when lysates were 
examined in this figure (Figure 19, first and second columns) the CTL, TL, and PGPH activities 
were normalized to the wild type activities observed at 180 min in the absence of inhibitors.  
Maximal, normalized activities are denoted as 100%. 
To assess the integrity of the proteasome using glycerol gradient centrifugation, the 
indicated cells expressing Add66p-myc under its endogenous promoter (Figure 26), an over-
expressing constitutive promoter (Figure 27), or an expression vector lacking an insert were 
grown in SC-LEU and 2% glucose at 30°C. A total of 100 ODs of mid-log phase cells were 
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harvested and washed once with water and resuspended in 2 ml of Buffer A lacking glycerol.  
(The pdr5Δ strain was incubated with 100 μg of MG132 for 1 h at 30°C prior to harvesting.)  
Cells were lysed as above and unbroken cells were removed by centrifugation in a Sorvall SS34 
rotor at 9,000xg for 30 min at 4°C.   Extracted proteins (5 mg total, as assessed using the Bio-
Rad protein assay kit with BSA as the standard) were fractionated on a 30 ml 4-25% linear 
glycerol gradient in an SW28 rotor (Beckman) at 83,000xg for 24 h at 4 °C.  Molecular mass 
markers (Sigma) were examined in parallel.  One ml fractions were removed and the refractive 
index was examined to verify the establishment of a linear gradient. Fractionated proteins were 
precipitated with trichloroacetic acid (TCA: 25% final concentration) and were resolved by SDS-
PAGE and analyzed as above by western blotting with anti-myc, anti-20S (BioMol), anti-HA 
(Roche Molecular Biochemicals), and anti-Cim5p (Ghislain et al., 1993) anti-sera.  
2.2.8 Non-denaturing PAGE proteasome activity assay 
A non-denaturing PAGE proteasome activity assay was slightly modified from a previously 
described method (Glickman et al., 1998).  In brief, 100 μg of clarified cytosol or 1 μg of 
purified 26S and 20S proteasomes were resolved on a non-denaturing single layer gel (0.18 M 
Tris-borate (pH 8.3), 5 mg MgCl2, 1mM ATP, 1mM DTT, and 4% acrylamide-bisacrrylamide 
(37:5:1 ratio)).  The running buffer was the same as the gel buffer but lacked acrylamide.  
Xylene cyanol was added to the samples prior to loading onto the gels.  The samples were 
resolved at 150mV at 4°C for approximately 2 h, allowing the xylene cyanol to run off. The gel 
was then incubated in 10 ml of 0.1 mM Suc-LLVY-AMC in buffer A (Section 2.2.7) for 10 min 
at 30°C.  Bands corresponding to the cleaved fluorescent substrate were visualized via the Kodak 
440CF Image Station when exposed to UV light (~360-380 nM wavelength).   
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2.2.9 Add66p-myc degradation assay 
The pdr5Δ yeast strain expressing Add66p-myc was grown in SC-LEU to mid-log phase at 30°C 
and protein synthesis was arrested by the addition of cycloheximide to a final concentration of 
100 µg/ml.  Four ODs of cells were removed at the indicated time points. The cells were washed, 
and total protein was isolated by glass bead lysis as detailed above. Proteins were resolved on 
either 12.5% or 18% polyacrylamide gels under denaturing conditions, and analyzed and 
quantified as above by western blotting with anti-myc and anti-Sec61p anti-sera.   
 
2.2.10 Induction of autophagy 
The indicated strains were grown overnight in YPD and 2.5 ODs of cells were diluted into 10 ml 
of rich medium (YP with 2% galactose) or nitrogen-depleted media (SC lacking ammonium 
sulfate but supplemented with 2% galactose) to induce autophagy.  After incubation for 5 h at 
30°C, equal numbers of cells were harvested and lysates were prepared by glass bead lysis as 
described above.  Equal amounts of protein (as assessed above) in each sample were resolved by 
SDS-PAGE and analyzed by western blotting using anti-Ape1p (Santa Cruz Biotechnology) and 
anti-Sec61p anti-sera. 
2.2.11 A1PiZ degradation assay in a genetically engineered mammalian cell line 
In collaboration with the Perlmutter laboratory, the HTO/Z cell line (HeLa cells with inducible 
expression of A1PiZ (Teckman et al., 2001) was transiently transfected with constructs 
 74 
engineered for the expression of PAC2 (pcDNA 3.0) or GFP (pCMV (Invitrogen)) using 
Superfect (Qiagen) and the manufacturer’s recommendations.  Twenty-four hours after 
transfection, the cells were harvested and homogenized by 12 passages through an 18 gauge 
needle in 10 mM Tris, pH 7.4, 1 mM EDTA, 150 mM NaCl, 0.5% NP40, 2 mM PMSF.  The 
homogenate was centrifuged to remove the insoluble material.  Total proteins in the soluble 
homogenate were then resolved by SDS-PAGE and subjected to western blot analysis by probing 
for A1PiZ (Diasorin), GFP (Abcam), or GADPH (US Biological). 
2.2.12 Radiolabeling, immunoprecipitation and phosphorimaging 
To assay A1PiZ expression, a previously published procedure was modified (Brodsky et al., 
1998).  In brief, yeast strains were grown over night at 30°C on selective solid medium 
containing 2% glucose.  A total of 20 OD600 cells were scraped from the plates using 4 ml of 
sterile water and switched to liquid selective medium lacking cysteine and methionine but 
containing 2% galactose to induce expression of A1PiZ.  Cells were immediately pulsed with 
200 μCi/ml of 35S-Easy Tag (NEN) and grown for 2 h at 30°C with vigorous shaking.  After this 
time, samples were harvested after the 2 h incubation.  Cell lysis and immunoprecipitation were 
performed as described (Brodsky et al., 1998) using antibodies against A1Pi (Rockland) and BiP 
and eluted off Protein A sepharose (GE Healthcare). Proteins were resolved by SDS-PAGE and 
visualized using a BAS-2500 (Fuji). Quantification was performed using ImageGuage version 
3.45 (Fuji). 
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2.3 RESULTS 
 
2.3.1 Pleiotropic phenotypes associated with add66Δ 
Growth phenotypes associated with mutations are one of the most basic tools of genetic analysis 
since a particular phenotype or a set of phenotypes can suggest a function for the corresponding 
gene product.  Therefore, a series of initial growth assays were performed comparing the wild 
type and mutant ADD66 strains in the presence of various temperatures and chemicals.  First, 
wild type cells and the add66Δ mutant strain were incubated on a variety of different growth 
media supplemented with various carbohydrate sources (Table 1).  No detectable differences 
were observed.  Second, exposure to media supplemented with different chemical compounds 
yielded no visible growth defects in the add66Δ strains relative to the wild type strain.  Finally, 
the wild type and mutant ADD66 strains grew identically when incubated at different 
temperatures (15, 26, 30, 35, and 37° C).  Furthermore, additive or synergistic effects of media 
supplemented with different chemicals or carbohydrates, in addition to incubation at elevated 
temperatures, yielded no visible growth defects for the mutant strain.  Many of these compounds 
have been linked to specific biochemical pathways; ideally, then any observed growth defects 
would indicate a relationship to a specific biochemical pathway (Hampsey, 1997). 
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 Table 1.  Growth Conditions and Associated Biochemical Pathways 
Growth 
Condition 
Associated 
Biochemical 
Pathway 
Growth 
Condition 
Associated 
Biochemical 
Pathway 
Growth 
Condition 
Associated 
Biochemical 
Pathway 
YP Raf Raffinose 
fermentation  
YP Suc sucrose 
fermentation 
YP Gal galactose 
fermentation 
YP Gly general 
respiration  
8 mM DTT ER protein 
folding  
- Inositol general 
transcription 
15 nM 
Caffeine 
MAP kinase 
pathway  
Various Salt 
Conditions 
and 
Concentrations
osmotic 
sensitivity 
Sorbitol osmotic 
sensitivity 
Hydroxyurea nucleic acid 
metabolism  
15 μM CdCl2 general 
protein 
folding 
and/or 
proteasome 
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 2.3.2 Genetic interactions between ADD66 and IRE1, a transducer of the Unfolded 
Protein Response (UPR) 
The Brodsky and McCracken labs previously reported on the identification of UPR-target genes 
in yeast that, when deleted, result in A1PiZ stabilization (Palmer et al., 2003).  In turn, the 
deletion of one gene, ADD66, induced the UPR, suggesting that the corresponding protein might 
be involved in more general aspects of ER quality control.  Therefore, I wished to examine the 
possible connection between Add66p and the UPR pathway.  As a control, one strain lacked 
Ire1p, an ER-resident transmembrane protein that senses a rise in the concentration of misfolded 
ER lumenal proteins and initiates the transcription of genes whose products lessen ER stress 
(Cox et al., 1993; Mori et al., 1993; Shamu and Walter, 1996; Credle et al., 2005; Zhou et al., 
2006).  The ire1Δ strain was examined along with add66Δ yeast and an ire1Δadd66Δ strain.  
These cells, as well as an isogenic wild type strain (see Table 2 located in Appendix A) were 
transformed with either a control plasmid or with a plasmid that expresses a ubiquitin-myc fusion 
protein under the transcriptional control of a copper inducible promoter.  As shown in Figure 
14A (right half of figure), I first observed that strains lacking Add66p showed a modest increase 
in polyubiquitinated proteins compared to the ADD66 strain (~2-fold in this experiment), and 
yeast deleted for IRE1—regardless of whether ADD66 was present—accumulated somewhat 
greater amounts of polyubiquitinated protein.  Though in another experiment, I found a more 
robust increase in polyubiquitinated proteins in the add66 deletion strain when compared to the 
ADD66 strain (~5-fold in this experiment (Figure 14B).  Furthermore, I noted that yeast lacking 
both ADD66 and IRE1 exhibited a strong, synthetic growth defect when incubated on media       
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Figure 14.  ADD6 and IRE1 synthetically interact.   
ADD66, add66Δ, ire1Δ and ire1Δ add66Δ strains were transformed with a control 
plasmid or a plasmid expressing a ubiquitin-myc fusion protein under the transcriptional control 
of a copper inducible promoter (“pCu Ubmyc”).  (A) Representative western blots of extracts 
from cells containing a vector control or the ubiquitin expression vector are shown.  Extracts 
were prepared after cells had been treated with 100 μM CuSO4 for 1 h at 30°C.  Blots were 
probed with anti-myc and anti-Sec61p (as a loading control). (B) A second representative 
western blot of extracts from cells containing a vector control or the ubiquitin expression vector 
is shown.  Extracts were prepared after cells had been treated with 100 μM CuSO4 for 1 h at 
30°C.  Blots were probed with anti-myc and anti-Sec61p (as a loading control). (C) Serial 
dilutions of the indicated strains (see Table 2 located in Appendix A) were grown on YPD in the 
presence or absence of 8 mM DTT, as indicated, for 48 h at 30°C.  Of note, I chose to examine 
DTT-sensitivity on YPD media at pH 6.5 to reduce alternate stresses, although previously 
published work demonstrated a greater sensitivity to DTT in the ire1Δ strain when grown using 
other conditions (Frand and Kaiser, 1998; Pollard et al., 1998).   
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 Figure 14.  ADD6 and IRE1 synthetically interact 
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containing DTT, a reducing agent that induces the UPR (Figure 14C).  These data support the 
hypothesis that Add66p plays a role in the turnover of polyubiquitinated proteins and ER quality 
control, and are consistent with reports indicating that mutations in genes required for both 
ERAD and the UPR exhibit synthetic phenotypes (Ng et al., 2000; Travers et al., 2000). 
In recently published work, autophagy has been shown to play a significant role in 
mediating A1PiZ degradation in yeast, mammalian cell culture, and mouse models (Teckman 
and Perlmutter, 2000; Kamimoto et al., 2006; Kruse et al., 2006).  Therefore, it was possible that 
deletion of ADD66 leads to the accumulation of A1PiZ and exhibits synthetic interactions with 
IRE1 because the autophagic pathway, which is induced by ER stress (Bernales et al., 2006; He 
et al., 2006; Ogata et al., 2006), is compromised.  To examine this hypothesis, the maturation of 
Ape1p, a protease that is targeted to the vacuole during autophagy, was assessed in both ADD66 
and add66Δ strains and in a well-characterized autophagy-deficient strain, atg14Δ  (Kametaka et 
al., 1998).  As Ape1p enters the vacuole it is proteolytically cleaved, and thus the conversion of 
immature-Ape1p (“pre-Ape1p”) to mature Ape1p (“m-Ape1p”) can be used to assess induction 
of autophagy (Suzuki et al., 2002).  As anticipated, I found that Ape1p failed to mature in the 
atg14 mutant, regardless of whether autophagy was induced upon nutrient starvation. In contrast, 
greater amounts of mature Ape1p were evident in both the wild type and add66Δ strains upon 
starvation (Figure 15). These data indicate that autophagy is proficient in yeast lacking ADD66.  
2.3.3 Add66p is a cytosolic, soluble protein 
To determine why cells deleted for ADD66 accumulate A1PiZ and polyubiquitinated proteins, I 
wished to characterize the gene product.  To this end, a sequence encoding the myc epitope was 
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 Figure 15. Autophagy is robust in the add66Δstrain.   
ADD66, add66Δ, and atg14Δ strains were grown in rich media (YPD) or in synthetic 
complete medium lacking ammonium sulfate (starvation media, or “Strv”).  Protein extracts were 
prepared from each strain, under each condition, and were resolved by SDS-PAGE and probed 
with an antiserum that recognizes the precursor (pre) and mature (m) forms of Ape1p.  Anti-
Sec61p antiserum was used as a loading control.  It should be noted that this assay only measures 
macroautophagy induction. 
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 Figure 15.  Autophagy is robust in the add66Δ strain 
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 appended onto the C-terminus of Add66p and the construct was cloned into a vector designed for 
the strong, constitutive expression of the desired protein (pGPD425) (Mumberg et al., 1995) or 
into a vector in which ADD66 expression was driven by the endogenous promoter (pRS315; see 
Section 2.2.3).  To determine if the tagged protein was active, I assessed whether A1PiZ 
degradation was restored to wild type levels in Add66p-myc-expressing add66Δ yeast.  To this 
end, Kristina Kruse of the McCracken lab utilized my constructs and employed a quantitative 
colony blot assay that reports on A1PiZ expression levels and ERAD, and in fact was used to 
isolate the ADD mutants (McCracken et al., 1996; Palmer et al., 2003).  As shown in Figure 
16A-B, A1PiZ accumulated to wild type levels when add66Δ cells contained the Add66p-myc 
expression vector.  I then examined the expression levels of A1PiZ in the various ADD66 and 
add66Δ strains.  As expected, Add66p-myc expression was observed only in ADD66 and add66Δ 
strains that had been transformed with the expression vector (Figure 16C).  
To determine Add66p’s residence, lysates were prepared from cells constitutively 
expressing epitope-tagged Add66p or containing a vector control, and the lysates were analyzed 
by differential centrifugation. Add66p was found exclusively in a high-speed supernatant (“S2”, 
Figure 17A), suggesting cytoplasmic residence.  Similar results were observed in strains 
expressing Add66p-myc expressed under the endogenous promoter (data not shown).  
Cytoplasmic residence was further supported through the use of indirect immunofluorescence 
microscopy: The anti-myc fluorescent signal exhibited a diffuse, cytoplasmic staining, unlike a 
marker for the ER, BiP, which was evident in perinuclear and peripheral patterns (Figure 17B). 
These data are consistent with earlier studies that attempted to define the localization of the vast 
majority of Saccharomyces cerevisiae proteins through the use of engineered GFP insertions at 
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Figure 16.  The A1PiZ degradation defect is rescued in add66Δ strains expressing Add66p-myc.   
(A) A colony-blot immunoassay was performed with anti-antitrypsin antiserum on 
add66Δ strains expressing A1PiZ lacking a vector or were transformed with an empty vector (-) 
or with an ADD66-myc expression plasmid (+).  (B) The results from three independent colony-
blot immunoassays were quantified for wild type yeast (ADD66) and add66Δ yeast that lacked a 
vector or were transformed with the ADD66-myc expression vector (+) or a vector control (-).  
Data were quantified from signals detected in the linear range of the analysis.  Data represent the 
means of three independent experiments, +/- SD:  The p value for the data for the ADD66 strain 
versus the add66Δ strain is <0.001.  The p value for the data for the ADD66 strain versus the 
add66Δ Add66pmyc (+) strain is <0.0001. The p value for the data for the ADD66 versus the 
add66Δ Add66pmyc (-) strain is <0.0005.  (C) Protein extracts were prepared from ADD66 and 
add66Δ yeast transformed with a vector control (-) or with the ADD66myc expression plasmid 
(+) and total proteins were resolved by SDS-PAGE.  The blots were probed with anti-myc and 
anti-Sec61p anti-sera.  Duplicate colonies were analyzed and are shown.   
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Figure 17.  Add66p is cytosolic.   
(A) add66Δ cells were transformed with a control plasmid or with a 2μ plasmid 
engineered for the constitutive expression of Add66p-myc.  Cell lysates (L) were subjected to 
16,000g and 150,000g centrifugations.  Total proteins in the pellets (P1 and P2) and supernatants 
(S1 and S2) were resolved by SDS-PAGE and analyzed by western blot analysis with anti-myc, 
anti-Sec61p (ER membrane protein), anti-Sse1p (a primarily cytosolic protein; (Goeckeler et al., 
2002)), and anti-Cim5p (a regulatory subunit of the 26S proteasome with cytosolic and ER 
membrane subcellular localizations) anti-sera. (B) Indirect immunofluorescence of add66Δ 
strains transformed with the plasmids described in part A were stained with DAPI (nuclear 
staining), and probed with anti-BiP (ER peri-nuclear and peripheral staining) and anti-myc anti-
sera and signals were detected as described in Section 2.2.5.   
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 Figure 17.  Add66p is cytosolic 
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 their C-termini (http://yeastgfp.ucsf.edu/).  Taken together, these data indicate that Add66p is a 
soluble cytosolic protein. 
2.3.4 Add66p is required for maximal proteasome activity 
A clue to Add66p’s function was provided by a large-scale yeast proteomic analysis in which the 
gene product was found in a multi-protein complex that included Pre1p (Ho et al., 2002).  Pre1p 
is a subunit in the 20S proteasome core that is one of two subunits that facilitates CTL activity 
(Heinemeyer et al., 1991; Hilt et al., 1993).  Add66p was also identified in a multi-protein 
complex with Pre5p (Krogan et al., 2006), a non-proteolytic subunit of the 20S proteasome 
(Heinemeyer et al., 1994), and with Ump1p, a protein required for the maturation of the 
proteasome core particle (Ramos et al., 1998).  These data suggested why add66Δ yeast 
accumulated polyubiquitinated proteins and why synthetic growth defects were observed when 
mutations in ADD66 and IRE1 were combined and ER stress was induced (Figure 14).  
Specifically, it suggests that Add66p is involved in proteasomal degradation and the removal of 
the protein results in the accumulation of misfolded protein substrates of the 26S proteasome.  
Therefore, I went on to examine the influence of Add66p on the proteolytic activity of the 26S 
proteasome. 
The activity of purified proteasomes has been measured and quantified utilizing an 
established fluorescence assay (Glickman and Ciechanover, 2002 and Section 2.2.7).  To 
facilitate the study of Add66p’s role in proteasome function, I modified this protocol to examine 
clarified cytosol in which the activities of the proteasomes could be assessed.  In each set of 
assays, the background (spontaneous) hydrolysis of the fluorogenic substrate was subtracted and 
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the resulting values for activity in the mutant lysates were normalized to the activity in the wild 
type lysates.  Previous studies on proteasome activities worked with approximately 1μg of highly 
enriched 26S proteasome (Glickman et al., 1998). Therfore, I examined 10-400 μg of clarified 
cytosol to determine if this was within the detectable and linear range of the CTL activity assay 
(Figure 18).  From this titration of cytosol concentrations, 100 μg of clarified cytosol was 
determined to be in the approximate linear range and was consequently utilized for subsequent 
assays.  The time dependence of the CTL, TL, and PGPH activity in each extract was also 
measured and compared to the activity in highly enriched 26S proteasomes (Figure 19).  From 
these experiments, 10 minutes was determined to be in the linear range for examining the CTL 
activity in yeast cytosol, and one hour was in the linear range for the TL and PGPH activity 
assays. 
To test directly whether the deletion of ADD66 affected proteasome function, the three 
proteolytic activities of the proteasome were measured in clarified cytosolic extracts derived 
from ADD66 and add66Δ strains using an established fluorescence assay (Glickman et al., 
1998).  As shown in Figure 19 and Figure 20A, I observed that the proteasome’s CTL activity—
which constitutes most of the proteasome’s activity—was markedly reduced in extracts from 
add66Δ yeast (BY4742).  To ensure that this effect was not strain-specific, the ADD66 gene was 
ablated in another strain background (W303) and a similar reduction in CTL activity was 
observed (Figure 20A, top panel, center).  As a control for these assays, I noted that all three 
activities were compromised in extracts prepared from a cim5-1 strain (Figure 20A, grey bars), 
which is known to exhibit delayed proteasome-dependent protein turnover, an elongated G2/M 
cell cycle transition, and growth arrest under various stress conditions (Ghislain et al., 1993; 
Rubin et al., 1998).   
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Figure 18.  CTL activity detection of varying amounts of yeast cytosol. 
 The chymotrypsin-like (CTL) activity in extracts prepared from the ADD66 strain was 
determined using a fluorogenic substrate, as described in section 2.2.7.  The indicated 
concentration of cytosol for each reaction is labeled below each bar.  Fluorescence was measured 
on a spectrofluorometer (emission at 380 nm and excitation at 436 nm) after 10 minutes.  The 
relative activities were normalized to the fluorescent signals of 400 μg of yeast cytosol, which 
was set at 100%.  Standard deviations were obtained from the results of three independent 
experiments. Data represent the means of three independent experiments, +/- SD. 
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 Figure 19.  Expression of Add66p-myc from its endogenous promoter complements the 
chymotrypsin-like activity defect in add66Δ yeast.   
The chymotrypsin-like (CTL), trypsin-like (TL) and peptidylglutamyl peptide 
hydrolyzing (PGPH) activities in extracts prepared from ADD66 (blue square) or add66Δ (red 
triangle) strains containing either a vector control or an Add66p-myc expression vector, or 
purified 26S proteasome (circles, last column), were determined using a fluorogenic substrate, as 
described in Section 2.2.7.  A total of 100 μg of cytosol and 0.5 μg of 26S proteasome was used 
in each reaction.  Fluorescence was measured on a spectrofluorometer (emission at 380 nm and 
excitation at 436 nm) at the indicated time points treated with DMSO (closed symbols) or 
inhibitor (open symbols; CTL: MG132, TL:  leupeptin, PGPH: MG-132).   The relative activities 
were normalized to the fluorescent signals for wild-type levels (first two columns) or the DMSO-
treated 26S proteasome (last column) at 180 min, which were set at 100%.  Data represent the 
means of three independent experiments, +/- SD.  The p value for the data for the CTL activity of 
the ADD666 strain versus the add66Δ strain without MG132 is 0.0001.  The p value for the data 
for the ADD66 strain versus the add66Δ strain with or without Add66myc and lacking treatment 
of a proteasome inhibitor is 0.7 or greater.  The p value for the data for the 26S proteasome in the 
presence versus the absence of inhibitor for the CTL, TL, and PGPH activities are less than or 
equal to 0.0001. 
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 Figure 19.  Expression of Add66p-myc from its endogenous promoter complements the 
chymotrypsin-like activity defect in add66Δ yeast 
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Figure 20.  The chymotrypsin-like activity of the 26S proteasome is reduced in extracts prepared 
from the add66Δ strain.   
The chymotrypsin-like (CTL), trypsin-like (TL) and peptidylglutamyl peptide 
hydrolyzing (PGPH) activities in clarified extracts from ADD66 (black bar) or add66Δ (white 
bar) yeast in two different strain backgrounds (BY4742 and W303) were determined.  
Proteasome activities in extracts from CIM5 and cim5-1 (grey bar) strains were used as a positive 
control.  The relative activity was determined by normalizing the fluorescent signals to the levels 
corresponding to the wild-type strains, as described in section 2.2.7.  Data represent the means of 
three independent experiments, +/- SD.  The p value for the data for the CTL activity of the 
ADD666 strain versus the add66Δ (BY4742 or W303) strains is 0.0005 or less.  The p value for 
the data for the ADD66 strain versus add66Δ strains for the TL or PGPH activities is 0.1447 or 
greater.  The p value for the data for the CIM5 strain versus cim5-1 strain for the CTL, TL, and 
PGPH activities are less than or equal to 0.001.  (B) Constitutive expression of Add66p-myc 
restores the CTL activity in the add66Δ strain.  Wild-type and add66Δ strains were transformed 
with an empty vector (-) or a vector engineered for the expression of Add66p-myc (+) and the 
CTL activity was analyzed as in part A.  Data represent the means of three independent 
experiments, +/- SD of the means.  The p value for the data for the CTL activity of the ADD666 
strain versus the add66Δ strain lacking the expression of Add66p-myc is 0.0023.  The p value for 
the data for CTL activity from the ADD66 strain versus the ADD66 or the add66Δ strains 
expressing Add66pmyc is 0.0875 or greater.  (C) Cytosolic proteins from the strains in (B) were 
resolved by SDS-PAGE and probed for Add66p-myc and Sse1p expression by western blot 
analysis.  Sse1p served as a loading control.  
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 Figure 20.  The chymotrypsin-like activity of the 26S proteasome is reduced in extracts prepared 
from the add66Δ complexes 
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I found that the constitutive, strong expression of Add66p-myc in the add66Δ strain 
complemented the CTL defect and restored activity to wild type levels (Figure 20B-C).  
However, it was unknown if over-expression of Add66p-myc would present some unforeseen 
secondary effect on proteasome activity.  Therefore, Add66p-myc was also expressed in strains 
under the control of its endogenous promoter and lysates were prepared from add66Δ yeast 
containing a vector control and the expression vector.  Here too I noted that the add66Δ CTL 
defect was complemented (Figure 19, “ADD66myc”).     
A complementary fluorescence assay was employed to confirm that the reduction in CTL 
activity observed in the add66Δ strain was due to a reduction of 26S proteasome activity 
(Glickman et al., 1998).  Equivalent amounts of ADD66, add66Δ, CIM5 and cim5-1 clarified 
cytosol, as well as purified 26S and 20S proteasomes, were resolved in a non-denaturing 
polyacrylamide gel and subsequently incubated with the fluorogenic substrate (Section 2.2.8).  
The gel was then subjected to UV light and the total signal of fluorescence was measured (Figure 
21).  Although this assay is not necessarily quantitative, I noted a general decrease in the CTL 
activity in the add66Δ mutant as well as in the cim5-1 strain.  It should be noted that there was no 
increase in 20S proteasomes in the add66Δ strain, while there was an increased level of CPs in 
the cim5-1 strain when compared to their respective isogenic wild type strains.   
The add66Δ mutant as well as five other add mutants were identified in the same screen 
(Palmer et al., 2003).  I therefore examined the proteolytic activities in four of the five other add 
mutants to determine if they had similar defects in proteasome activity (Figure 22).  Although 
varying levels of proteolytic activities were observed, the add66Δ mutant consistently showed a 
reduction in the chymotrypsin-like activity.  A possible explanation for this range of observed 
activities from each add mutant strain is that the strains were obtained from a commercial source  
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Figure 21.  26S proteasome activity is reduced in the add66Δ strain with no increase in the 
relative level of 20S particles. 
One hundred μg of clarified cytosol from the ADD66, add66Δ, CIM5 or cim5-1 or 1 μg 
of purified 26S or 20S proteasome were resolved on a non-denaturing PAGE gel.  The gel was 
then incubated 0.1 mM Suc-LLVY-AMC and proteasome bands were visualized via a Kodak 
440CF Image Station upon exposure to UV light (~360-380 nM).  (A) Quantification of the 
relative proteasome activity by measuring the combined levels of 26S and 20S activities of the 
above yeast strains.  The combined relative proteasome activity was determined by normalizing 
the fluorescent signals to the levels corresponding to the wild-type strains.  Wild type strains 
were normalized to 100% activity.  The bars show a range of activities from two independent 
experiments.  (B)  A representative blot of proteasome activity of all the above samples.  The 
relative sizes of 26S and 20S proteasomes are depicted to the left of the gel.  The faster migrating 
intermediate band in the 26S lane is possibly the result from one of the 19S regulatory caps 
disassociating from the 26S proteasome complex. 
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 Figure 22.  The proteolytic activities of the 26S proteasome extracts prepared from various add 
strains.   
Extracts prepared from ADD, add6Δ, add37Δ, add66Δ, add67Δ, and add68Δ strains  (Palmer et 
al., 2003) were examined for the chymotrypsin-like (CTL), trypsin-like (TL), and 
peptidylglutamyl peptide hydrolyzing (PGPH) activities.  100 μg of clarified cytosol was used 
for each reaction.  Fluorescence was measured on a spectrofluorometer (emission at 380 nm and 
excitation at 436 nm).  The relative activities were determined by normalizing the fluorescent 
signals to those observed in extracts prepared from the ADD (wild-type) yeast, which was set at 
100%.  Standard deviations were determined from the means of four independent experiments 
with a p values comparing the data from the wild type strain to the isogenic mutant strain ( CTL, 
PGPH, and TL respectively):  add6Δ (0.001, <0.0001, and 0.0011), add37Δ (0.015, 0.004, and 
0.0516), add66Δ (<0.0001, 0.0008, and < 0.0001), add67Δ (0.035, < 0.0001, and 0.0235), and 
add68Δ (0.001, 0.001, and 0.006). 
 100 
 Figure 22.  The proteolytic activities of the 26S proteasome extracts prepared from various add 
strains 
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(BY4742, Research Genetics).  Strains in this commercial collection have been noted to have 
additional mutations and thus may not be homogeneous.  In the future, it would be worthwhile to 
reconstruct these mutations in another strain background and reassess the CTL acitivty. 
Combined with the fact that Add66p-myc rescues the A1PiZ degradation defect in 
add66Δ yeast (Figure 16), all these data indicate that Add66p is required for maximal CTL 
activity and strongly suggest that the A1PiZ degradation defect in add66Δ yeast arises from 
reduced proteasome activity.   
2.3.5 The levels of 26S proteasome subunits are unaltered in the add66Δ strain  
The simplest explanation for the reduced CTL activity in extracts derived from add66Δ yeast is 
that the number of proteasomes is decreased in this strain.  As demonstrated earlier (Figure 21), 
there appeared to be no significant accumulation of 20S complexes in the add66Δ strain.  
However, the reduced CTL activity observed in the ADD66 mutant strain could be the result of a 
decrease in the individual amount of subunits in the 26S complexes.  To address this possibility, 
quantitative immunoblotting was employed to measure the levels of six 20S subunits, using a 
non-specific polyclonal antiserum, and one 19S subunit (Cim5p) in the add66Δ and wild type 
strains (Figure 23).  However, no significant difference in the relative levels of these subunits 
was detected.   
2.3.6 The relative affinities of the subunits that mediate the CTL activity for specific 
inhibitors are not altered in extracts prepared from add66Δ yeast 
Pre1p is one of the two essential 20S subunits required for the CTL activity of the proteasome 
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Figure 23.  The levels of 26S proteasome subunits are unaltered in the add66Δ strain.   
(A) Proteins in clarified cytosol from ADD66 (black bar) and add66Δ (white bar) yeast 
were resolved by SDS-PAGE and western blot analyses were performed to detect the levels of 
20S subunits, a component of the 19S particle (Cim5p), Sse1p, and Hsp82p.  Relative protein 
levels were determined by quantifying the intensities of the various proteins, and then 
normalizing these values to the levels measured in the isogenic wild type strain. Data represents 
the means of eight independent experiments, +/- SD, with a p value comparing the data for the 
ADD66 strain to the add66Δ strain of 0.36559 or greater for each protein.  (B) A representative 
western blot used to amass the data in part A. 
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 Figure 23.  The levels of 26S proteasome subunits are unaltered in the add66Δ strain 
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(Heinemeyer et al., 1991; Hilt et al., 1993).  Because reduced CTL activity was observed in 
extracts from ADD66-deleted cells (Figure 19, 20A, 21, and 22), it was possible that the absence 
of the corresponding protein might grossly alter the conformation of Pre1p’s substrate binding 
site.  To test this hypothesis, the CTL activity was assayed in extracts from wild type and add66Δ 
strains in the presence of increasing concentrations of MG-132 and epoximycin.  MG-132 and 
epoxomicin specifically block the CTL activities in nearly irreversible non-covalent and covalent 
manners, respectively (Gaczynska and Osmulski, 2005).  As shown in Figure 24, there was no 
difference in the apparent KIs for these inhibitors (~5 x 10-7 M) when titrated into cytosols 
prepared from wild type or add66Δ yeast. This result suggests that the conformation of the Pre1p 
substrate-binding site was not radically altered. 
2.3.7 20S precursors accumulate in yeast deleted for ADD66 
The 26S proteasome is comprised of at least 31 different subunits that combine in a spatially and 
temporally defined manner via various intermediate complexes (Ramos et al., 1998; Voges et al., 
1999; Tone et al., 2000; Hirano et al., 2005).  Although little is known about the exact 
mechanism by which the proteins in the cap and the 7 distinct alpha and 7 beta subunits in the 
core assemble (See Section 1.1.1 for further details), two proteins were previously identified that 
are required for the proper maturation of the core particle in yeast: Nob1p and Ump1p (Ramos et 
al., 1998; Tone et al., 2000).  Mutations in NOB1 exhibit defects in the processing of 20S beta 
subunits, which are the central, proteolytic subunits, and in the assembly of the 20S and 26S 
particles (Tone and Toh, 2002).  In addition, as described above, Ump1p co-precipitates with 
Add66p in a multi-protein complex (Krogan et al., 2006) and mutations in UMP1 affect the 
function of all three proteolytic activities due to defects in beta subunit maturation  
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Figure 24.  The relative affinities of the subunits that mediate the CTL activity for specific 
inhibitors are not altered in extracts prepared from add66Δ yeast.   
The CTL activities in extracts prepared from ADD66 (open circles) and add66Δ (closed 
circles) strains were determined (as described in Section 2.2.7) at the indicated concentration of 
(A) epoxomicin and (B) MG-132. The relative activity was determined by normalizing the 
fluorescent signals to wild-type levels in reactions lacking inhibitor. The structures of the 
inhibitors are shown, and the data represents the means of four independent experiments, +/- SD. 
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 Figure 24.  The relative affinities of the subunits that mediate the CTL activity for specific inhibitors 
are not altered in extracts prepared from add66Δ yeast 
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(Ramos et al., 1998).  Thus, it was possible that Add66p participates in proteasome subunit 
maturation and/or assembly.  Moreover, I found that ADD66 is 20% identical to proteasome 
assembly chaperone “2” (PAC2; Figure 25.  This region of similarity between ADD66 and PAC2 
has been identified by other research groups (Hirano et al., 2005; Li et al., 2007).  PAC2  was 
shown to facilitate the assembly of the 26S proteasome in mammals (Hirano et al., 2005).  PAC2 
is also known as CLAST3 and HCCA3; a gene that is up-regulated in hepatic cancers (Wang et 
al., 2001; Bahar et al., 2002).  Based on these published observations and my data presented 
above, I examined whether 20S proteasome assembly intermediates accumulate in yeast lacking 
Add66p. 
Extracts derived from the ADD66 or the add66Δ strains transformed with a control 
plasmid or with the Add66-myc expression plasmid were fractionated on a glycerol density 
gradient.  A low percentage (4-25%) glycerol gradient was used in this experiment to better 
resolve early proteasome intermediates.  This technique was previously employed to note 
assembly intermediates in mammalian cells when PAC2 expression was silenced (Hirano et al., 
2005).  I first observed that the majority of 20S subunits and a component of the 19S cap 
resolved at fractions in the gradient that corresponded to particles with a molecular mass of ~2.5 
MDa (Figure 26).  This value is in good agreement with the native size of the 26S proteasome.  
Second, I observed a 20S immuno-reactive protein in a distinct, lighter fraction when extracts 
from the add66Δ strain were examined (see downward arrow, add66Δ, ”α−20S”).  This species, 
which migrated at ~300 kDa, was absent when extracts from wild type cells or from add66Δ 
yeast expressing endogenous levels of Add66p-myc were examined.  Third, I found that the same 
20S immuno-reactive species was present when extracts were resolved from yeast lacking  
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Figure 25.  Sequence alignment of human PAC2 and yeast Add66p. 
Single letter amino acid alignment of the full length sequence from human PAC2 
(Accession number: CR457181) and yeast Add6p (Accession number Z28206 Y13137).  
Sequence identities are shown in black.  Sequence alignment was performed by EMBOSS 
(needle) pairwise alignment algorithms (Blousum62: Gap open 10: Gap extend 0.5)   
(http://www.ebi.ac.uk/emboss/align/).. 
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PAC2        1 MFVPCGESAPDLAGFTLLMPAVSVGNVGQLAMDLIISTLNMSKIGYFYTD     50 
Add66p      1              MSCLVLPLVSVGNIPQLSIDWL---LNSQANEWEYLE     34 
 
PAC2       51 C-----LVPMVGNNPYATTEGNSTELSINA--------EVYSLPSRKLVA     87 
Add66p     35 ALDSKYLVEFVG--PLDRPEDGSDSLYKDADMKYSSALEVFYNKKRGLFA     82 
 
PAC2       88 LQLRS--IFIKYKSKPFCEKLLSWVKSSGCARVIVLSSSHS---------    126 
Add66p     83 IQQRTPLVSVNYLNNFIVEIILPFLSKYNISEICIWDSLYAMEDENGVIV    132 
 
PAC2      127 -----------YQRNDLQLRSTPFRYLLTPSMQKSVQNKIKSLNWEEMEK    165 
Add66p    133 RPQEVYSLGEFYFDDEAELLSN-----LHLNDQESMVN-----NWLHF--    170 
 
PAC2      166 SRCIPEIDDSEFCIRIPGGGITKTLYD-ESCSKEIQMAVLLKFVS----E    210 
Add66p    171 ---TPTSFQDKISVDQP---IFKILFQILNASQRPKALRSIKYCSCLANE    214 
 
PAC2      211 GDNIPDALGLVEYLNEWLQILKPLSDDPTVSASRWKIPSSWRLLFGSGLP    260 
Add66p    215 GDNSLDS----QQFLQWIISQKVIKNAPPI--VKFVRPISWQGAYGMADA    258 
 
PAC2      261 PALF                                                  264 
Add66p    259 RDKFVDLYN                                             267 
 
 
 
Figure 25.  Sequence alignment of human PAC2 and yeast Add66p 
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Figure 26.  Yeast deleted for ADD66 accumulate a 20S intermediate and unprocessed 20S 
subunits.  
Cell extracts were prepared from an ADD66 and add66Δ strain containing either a control 
plasmid or a plasmid engineered for the endogenous expression of Add66p-myc, and from a 
UMP1 (JD133) and ump1Δ (JD134) strain. A total of 5 mg of protein was then resolved on a 
linear glycerol gradient (4-25%) and fractions were collected.  Proteins in every other fraction 
were examined for the presence of 20S subunits, a component of the 19S subunit (Cim5p), and 
Add66p-myc by western blot analysis.  The migrations of molecular mass markers, which were 
analyzed in parallel, are indicated below the gel, the black downward bracket indicates fractions 
containing immature 20S subunits (a slower migrating doublet), and the black downward arrow 
indicates the migration of a 20S assembly intermediate.  Note that the later two were observed 
only in extracts prepared from add66Δ and ump1Δ cells.  The immuno-reactive HA species in 
the UMP1 and ump1Δ gradients represents Pre2p (see Table 2 located in Appendix A). 
 111 
 Figure 26.  Yeast deleted for ADD66 accumulate a 20S intermediate and unprocessed 20S subunits 
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Ump1p (ump1Δ, ”α−20S”), a factor required for 20S maturation (Ramos et al., 1998).  Fourth, 
when extracts were examined from add66Δ or ump1Δ yeast, a 20S, slower-migrating doublet 
was observed that fractionated at the native size for 26S proteasomes (see downward bracket).  
Previous work demonstrated that one of the species in the doublet represents an unprocessed beta 
subunit in the 20S proteasome (Ramos et al., 1998).  This result suggests some overlap in the 
defects during 20S subunit processing in the add66Δ and ump1Δ strains.  And fifth, I found that 
Add66p resided at a position consistent with a molecular mass of ~150-300 kDa, suggesting that 
Add66p, an ~30 kDa protein, is a component of a multi-protein complex and/or forms higher-
order oligomers (see Chapter 4, below, and Li et al., 2007).  Over-expression of Add66p-myc 
was also able to decrease the amount of the immature 20S doublet and of the ~300 kDa assembly 
intermediate (Figure 27), although the Add66p-myc instead resolved in fractions corresponding 
to a molecular mass of ~66-150 kDa. This suggests that over-expression of Add66p-myc rescues 
the add66Δ   20S maturation defect, but also results in improper association with itself and/or 
other proteins.  Together, these data indicate that yeast deleted for ADD66 accumulate an 
intermediate in the 20S assembly pathway, similar to what was observed in ump1Δ and nob1Δ 
strains (Ramos et al., 1998; Tone et al., 2000). 
2.3.8 The stability of the 26S proteasome is not reduced in the add66Δ strain 
Another explanation for these findings is that the overall stability of the 20S proteasome is 
compromised in the add66Δ strain and that the particle is labile in extracts derived from the 
add66Δ strain and breaks-down during gradient centrifugation.  To test this possibility, I treated 
wild type and add66Δ extracts with two concentrations of detergent, which I predicted to either  
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Figure 27.  Fractionation of proteasomes in lysates prepared after Add66p-myc over-expression 
in wild type and add66Δ yeast.  
Cell extracts were prepared from an ADD66 and add66Δ strain containing a plasmid 
engineered for the constitutive, strong over-expression of Add66p-myc. A total of 5 mg of 
protein were then resolved on a linear glycerol gradient (4-25%) and fractions were collected.  
Proteins in every other fraction were examined for the presence of 20S subunits, a component of 
the 19S subunit (Cim5p), and Add66p-myc by western blot analysis.  The migrations of 
molecular mass markers, which were analyzed in parallel, are indicated below the gel. 
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Figure 27. Fractionation of proteasomes in lysates prepared after Add66p-myc over-expression in 
wild type and add66Δ yeast 
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modestly or vigorously disrupt the integrity of the particle. The proteins in these treated extracts, 
as well as untreated samples, were fractionated on a 10-40% glycerol density gradient to resolve 
various proteasome complexes.  As shown in Figure 28, all of the 20S immuno-reactive species 
fractionated at ~2.5 MDa—a size that corresponds to the native 26S particle—when extracts 
were examined from wild type or ADD66-deleted cells.  In contrast, when extracts from ADD66 
and add66Δ cells were treated with 0.02% SDS the 20S subunits eluted in fractions consistent in 
size with a half proteasome complex at ~400 KDa.  Treatment of cell extracts with 0.05% SDS 
further disrupted the 20S proteasomal subunits into smaller complexes that migrated at ~200-300 
KDa.  In each case, no significant differences were observed between gradients that employed 
extracts from ADD66 and add66Δ cells, suggesting that the 26S particles, once assembled, are 
equally stable in wild type and add66Δ yeast. 
2.3.9 Add66p is degraded by the 26S proteasome 
A number of proteasome chaperones interact transiently with early proteasome assembly 
intermediates, and in some cases are then degraded by the proteasome (Ramos et al., 1998; Tone 
et al., 2000; Tone and Toh, 2002; Hirano et al., 2005).  I therefore incubated a pdr5Δ Add66p-
myc expressing strain with either DMSO or MG-132.  The pdr5Δ strain was employed based on 
the fact that this mutation, like other similarly employed mutations, disables a plasma membrane 
drug efflux pump; therefore, the effect of proteasome inhibitors is magnified (Balzi et al., 1994; 
Lee and Goldberg, 1996).  As shown in Figure 29A, Add66p-myc shifts to fractions containing 
complexes of greater molecular masses, which contain 20S subunits, when extracts were 
prepared from cells treated with MG-132.  Treatment with MG-132 also results in the 
accumulation of the slower-migrating, 20S “doublets”, as seen when extracts were examined  
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Figure 28.  The stability of the 26S proteasome is not reduced in the add66Δ strain.   
Extracts were prepared from ADD66 or add66Δ strains and 5mg of protein were resolved 
on a linear glycerol gradient (10-40%).  Gradients contained 0%, 0.02% or 0.05% SDS, which 
were analyzed in parallel. Proteins in every other fraction were immunoblotted for the indicated 
proteins or epitope tags.  Size markers are indicated below the figure. 
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 Figure 28.  The stability of the 26S proteasome is not reduced in the add66Δ strain 
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Figure 29.  Add66p is degraded by the 26S proteasome.   
A pdr5Δ strained transformed with a plasmid designed for the constitutive expression of 
ADD66myc was incubated either with 100 μM MG-132 or the equivalent volume of DMSO for 1 
h at 30°C.  (A) Cell extracts from each strain were prepared and 5 mg of protein were resolved 
on a linear glycerol gradient (4-25%) and fractions were collected.  Proteins in every other 
fraction were immunoblotted for 20S subunits, a component of the 19S subunit (Cim5p), and 
Add66p-myc.  Molecular mass markers, which were analyzed in parallel, are indicated below the 
gel. Note that these blots were purposely over-exposed (compared to those in Figure 26).  (B) 
The strains described in part A were harvested at the indicated time points after the addition of 
cycloheximide, and cell extracts were prepared and subjected to SDS-PAGE and immunoblotted 
for Add66p-myc and Sec61p (as a loading control).  The amount of Add66p-myc at the start of 
the chase in each strain, after standardization to the amount of Sec61p at each time point, was set 
to 100%: (О), MG-132; (●), DMSO control.  The data represent three independent experiments, 
+/- SD, with p values of 0.0812 (30 min), 0.0323 (60 min), and 0.0065 (90 min) when comparing 
the strain with and without MG132 treatment. 
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 Figure 29.  Add66p is degraded by the 26S proteasome 
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from add66Δ and ump1Δ strains (Figure 26) when the blots were over-exposed (data not shown).   
Next, to examine whether Add66p, like several other proteasome chaperones, is degraded 
by the proteasome, a cycloheximide chase was performed in the presence or absence of MG-132.  
Once again, the pdr5Δ strain was transformed with a plasmid engineered for the constitutive 
expression of Add66p-myc and the cells were incubated with either DMSO or MG-132 for 1 
hour prior to the chase (Figure 29B). Although Add66p was rapidly degraded in cells treated 
with DMSO, I discovered that the addition of MG-132 to wild type yeast cells resulted in a 
profound, reproducible stabilization of the protein, indicating that Add66p is a proteasome 
substrate. 
2.3.10 A1PiZ expression in the add66Δ yeast strain 
Even though the add66Δ strain displayed no visible phenotype when incubated on media 
supplemented with various carbohydrates or chemicals and incubated at elevated temperatures 
(Table 1), I observed a significant growth defect in ~15% of A1PiZ-expressing add66Δ cells (see 
Figure 30 for one example).  Furthermore, these add66Δ cells had not obtained secondary 
mutations in the gene required for galactose utilization (Figure 30 last panel); i.e. a gal- 
phenotype might have given rise to this observation. This was shown by rescuing the A1PiZ-
expression vector from add66Δ strains that were either inviable or viable on galactose-containing 
media, and then retransforming them with the expression vector. I found that this phenomenon 
most commonly arose stochastically since in any given transformation ~15% of the 
transformants containing the pGAL A1PiZ expression vector failed to grown on galactose (data 
not shown).   
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 Figure 30.  Over expression of A1PiZ in add66Δ yeast can result in lethality.   
Ten-fold serial dilutions of ADD66 and add66Δ transformed with either control plasmids 
or plasmids expressing A1PiM or A1PiZ (all of which were URA-marked) under the 
transcriptional control of a galactose inducible promoter were grown at 30°C for 48 h on YPD, 
SC-URA+GLC, or SC-URA+GAL (left half of figure).  The growth defect in the add66Δ strain 
expressing A1PiZ in the presence of galactose was seen in ~15% of transformants after 50 
individual transformants were examined (one transformant in which this phenomenon was 
observed is denoted by an asterisk, and a transformant in which growth was unaffected is 
denoted by a double-dagger).  To establish that the lethal phenotype was not because the cells 
had become auxotrophic for galactose utilization (i.e., Gal-), the following protocol was 
followed: add66Δ strains transformed with either a control plasmid or a plasmid containing 
A1PiM or A1PiZ under the transcriptional control of a galactose inducible promoter were re-
plated three times in the presence of 5FOA (in order to select for cells lacking the expression 
vector).  Next, the resulting cultures (right half of figure) were serial diluted on 5FOA (to 
confirm selection for yeast lacking vector), SC-URA+GAL (to confirm that the yeast did indeed 
lack the URA-marked vector), or SC-URA+GAL (to confirm the Gal+ phenotype).  
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 Figure 30.  Over expression of A1PiZ in add66Δ yeast can result in lethality 
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Because it has been proposed that generic variations and/or stochastically elevated 
expression levels might modify the degradation efficiency and/or solubility of proteins 
associated with conformational diseases (Perlmutter, 2002; Kamimoto et al., 2006), I reasoned 
that this phenomenon might have been recapitulated in A1PiZ-expressing yeast.  One possibility 
is that the protein is expressed at different levels in each yeast cell, and that only add66 mutants 
expressing the highest levels of A1PiZ were inviable.  To test this hypothesis, I measured the 
A1PiZ expression levels by immunoprecipitation of radiolabeled A1PiZ at early time points after 
A1PiZ expression was induced in add66Δ cells that either succumbed (GD) or survived (ND).  
Examination of A1PiZ expression within 4 hours of A1PiZ induction showed that cells that 
succumbed to a growth defect did so within 2 hours of induction (i.e., a switch from glucose to 
galactose containing media (data not shown)).  However, the level of A1PiZ expression within 2 
hours of induction was identical in both strains (Figure 31).   
Because the add66Δ growth defect shown in Figure 30 represents the stationary phase of 
growth, a series of growth curves were calculated from dividing ADD66 and add66Δ strains on 
selectable media containing various carbon sources that affect A1PiZ expression system (Figure 
32).  Very little growth was observed over the time course in the wild type and add66Δ strains 
transformed with an expression vector inserted with A1Pi in selectable media containing 2.0% 
galactose (data not shown).  In an effort to regulate the levels of the galactose inducible 
promoter, media containing 0.2% glucose and 2.0% galactose was utilized to limit the expression 
of AT.   ADD66 strains showed no defect in the doubling time when containing an empty  
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Figure 31. Expression of A1PiZ in different add66Δ strains 
Representative image from a radiolabeled immunoprecipitation of A1PiZ expression in 
various yeast strains.  Equivalent levels of cells from add66Δ strains that eventually either 
succumbed (GD) or survived (ND) induction of A1PiZ or an add66Δ strain containing an empty 
vector (V) were radiolabeled for 2 hours.  Cells were lysed and immunoprecipitated for BiP (as a 
loading control) and A1PiZ.  Cells that eventually succumbed to A1PiZ expression were still 
viable at this time point.   
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 Figure 31.  Expression of A1PiZ in different add66Δ strains 
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Figure 32.  add66Δ yeast that succumb to A1PiZ expression stop growing at relatively early 
times when A1PiZ is induced.   
Wild-type and add66Δ strains were transformed with expression plasmids containing 
A1PiM or A1PiZ under the control of a galactose inducible promoter or with the expression 
vector lacking an insert (pYes2).  Equivalent numbers of transformed cells were grown for 18 h 
in selectable medium containing 2.0% raffinose and then switched to selectable media containing 
2.0% glucose (Glc), or 2.0% galactose and 0.2% glucose for a 12 h time course at 30° C.  Every 
2 h the optical density (OD at 600 nm) of the culture was determined by a spectrophotometer and 
charted on a log scale. 
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 Figure 32.  add66Δ yeast that succumb to A1PiZ expression stop growing at relatively early times 
when A1PiZ is induced  
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expression vector or a vector expressing wild type (A1PiM) or the Z mutant.  In contrast, a 
significant defect in the doubling time was observed in add66Δ pYes2A1PiZ yeast (that  
succumbed to A1PiZ expression) after 8 hours, which is most likely due to the accumulation of 
high levels of the toxic A1PiZ polymer in the cells (Kruse et al., 2006).  Furthermore, add66Δ 
strains that do not succumb to A1PiZ expression did not show a similar defect (data not shown).  
Overall, the nature of this growth defect in A1PiZ expressing yeast is not clear. 
2.3.11 PAC2 over-expression enhances A1PiZ degradation HELA cells. 
As shown in Figure 25, Dr. Jeffrey Brodsky noted that a region in a mammalian protein exhibits 
low sequence identity with Add66p; during the course of my studies, a similar finding was 
reported by the Murata lab and the mammalian protein was characterized as PAC2, proteasome 
assembly chaperone-2 (Hirano et al., 2005).  PAC2 was also recently noted by the Hochstrasser 
lab to share 19% identity with ADD66, which they called PBA2 for proteasome biogenesis 
associated polypeptide (Li et al., 2007).  Because PAC2 is expressed in hepatocytes (Wang et al., 
2001), the tissue in which A1Pi is synthesized, and because PAC2 over-expression accelerates 
proteasome biogenesis (Hirano et al., 2005), I hypothesized that PAC2 over-expression might 
help clear A1PiZ in mammalian cells.  In collaboration with the Perlmutter lab, I cloned PAC2 
into a mammalian expression vector (See section 2.2.3).  Subsequently, Béla Schmidt of the 
Perlmutter lab utilized a HeLa cell line that stably expresses A1PiZ (Teckman et al., 2001) and 
these cells were transiently transfected with vectors to drive the expression of PAC2 or GFP.  
We found that the HeLa cells over-expressing PAC2 showed a concentration-dependent 
reduction in the amount of A1PiZ, whereas the levels of A1PiZ were unaffected in cells 
transfected with equal amounts of the GFP-encoding DNA (Figure 33).  These data suggest  
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Figure 33.  PAC2 over expression enhances A1PiZ clearance in HeLa cells.   
HeLa cells stably expressing A1PiZ were transiently transfected with pcDNA3.0 
containing either the PAC2 or GFP coding sequences in the amounts indicated.  Cells were 
harvested, and cell extracts were prepared and subjected to SDS-PAGE.  Western blots for 
A1PiZ, GFP, and GADPH (as a loading control) were then performed.    
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 Figure 33.  PAC2 over expression enhances A1PiZ clearance in HeLa cells 
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that PAC2 plays a role in the clearance of A1PiZ, perhaps similar to the role that Add66p plays 
during the degradation of A1PiZ in yeast (Palmer et al., 2003).  
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3.0  THE REGULATION OF ADD66 DURING THE UNFOLDED PROTEIN 
RESPONSE 
3.1 INTRODUCTION 
The accumulation of unfolded proteins in the endoplasmic reticulum (ER) activates a 
transcriptional induction process termed the unfolded protein response (UPR) (Kaufman, 1999; 
Patil and Walter, 2001).  In Saccharomyces cerevisiae, the basic leucine zipper containing 
transcription factor Hac1p is responsible for transcriptional induction of a relatively small 
number of  the approximately 380 UPR-target genes that have been identified (Cox and Walter, 
1996; Mori et al., 1996; Travers et al., 2000).  The transcription of many other UPR targets 
appear to be activated by the Gcn4p transcription factor, which is not sufficient to bind UPR 
targets during permissive conditions; however up-regulation of the gene, as seen during ER 
stress, does cause an induction of the UPR (Patil et al., 2004).  In any event, targets of the UPR 
include ER localized molecular chaperones, components of the ER-associated degradation 
machinery, and numerous proteins involved in various aspects of the secretory pathway.  These 
proteins alleviate the accumulation of unfolded proteins residing within the ER.  Induction of 
these UPR targets is crucial for ER homeostasis under stress conditions and cells unable to 
induce the UPR are highly sensitive to ER stress (Kaufman, 1999; Patil and Walter, 2001). 
The expression and activity of Hac1p are tightly regulated at the level of mRNA splicing.  
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HAC1 mRNA is constitutively synthesized but contains an un-spliced intron under non-stress 
conditions (Cox and Walter, 1996; Kawahara et al., 1997).  Splicing of HAC1 precursor mRNA 
is initiated by Ire1p-mediated processing, and is the result of ER stress (Sidrauski and Walter, 
1997).  Ire1p is a transmembrane protein kinase with endoribonuclease activity, and is activated 
by ER stress-induced homodimerization and subsequent autophosphorylation (Cox et al., 1993; 
Mori et al., 1993; Shamu and Walter, 1996; Welihinda and Kaufman, 1996).  It is not yet clear 
how unfolded ER proteins activate the cytosolic nuclease activity of Ire1p. 
Splicing regulates the activity of Hac1p in two ways. First, Hac1p is synthesized only 
after splicing occurs, since the HAC1 intron inhibits translation (Kawahara et al., 1997).  Second, 
activity of Hac1p artificially translated from spliced mRNA is much stronger than that of Hac1p 
translated from un-spliced mRNA.  This is the result of the DNA-binding domain being encoded 
by the first exon, whereas the activation domain is encoded by the second exon (Mori et al., 
2000).   Regardless, the subsequent activation of Hac1p target genes in the nucleus occurs via 
direct binding to a cis-acting UPR element (UPRE) (Mori et al., 1992; Mori et al., 1998).  The 
UPRE was originally defined as a 22-bp sequence that up-regulates the transcription of KAR2, 
the gene that encodes yeast BiP  (ER lumenal Hsp70p) (Mori et al., 1992).  The necessity of the 
22-bp sequence has since been simplified to a 10-bp core sequence and has subsequently been 
reduced to an essential seven nucleotide E-box-like palindrome (CAGNGTG) (Mori et al., 
1998).   
In this chapter, I report on the characterization of a nucleotide sequence up-stream of the 
coding region of ADD66, which is likely involved in its transcriptional regulation during times of 
ER stress.   The ADD66 gene is known to be up-regulated during ER stress via the UPR and 
strains lacking ADD66 initiate the UPR (Travers et al., 2000; Palmer et al., 2003).  Furthermore, 
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the nucleotide sequence that I identified upstream of ADD66 shows similarity to the consensus 
sequence recognized by Hac1p, suggesting that Hac1p may regulate ADD66.  Interestingly, the 
putative UPRE resides in the gene upstream of ADD66, which is known as LOS1.   
3.2  MATERIALS AND METHODS 
3.2.1 Strains and growth conditions 
An add66Δ disruption cassette was obtained by amplifying pRS400 (Brachmann et al., 1998) 
with the following oligonucleotides: 5’ ACT TCA GGA AAG AAT AGC ACA AAA CCC 
AAA GGA ACA TAC GCT GTG CGG TAT TTC ACA CCG 3’ and 5’ ATA TAT GCA CTT 
GTA TAG AAA ACA GAT ATA CTT CTC GGT TAG ATT GTA CTG AGA GTG CAC.  An 
los1Δ disruption cassette was obtained by amplifying pRS400 (Brachmann et al., 1998) with 
insertion of a KanMX gene utilizing the following oligonucleotides: 5’ AAG CAA CCT ATA 
GAA CAA GTG TTT CCA GTC AAA TCG AGG ACT GTG CGG TAT TTC ACA CCG 3’ 
and 5’ TAT TCT TAT TTA CGG AGG TGG CTG TGA CTG CAG TGT CTA TAG ATT GTA 
CTG AGA GTG CAC 3’.  ADD66 and LOS1 mutants were then isolated on G418-containing 
medium as previously described (Brachmann et al., 1998). 
All yeast strains used in this study are detailed in Table 2 (located in Appendix A) and 
were grown on yeast extract-peptone (YP)-dextrose (YPD (2%)) medium. Yeast were grown at 
the indicated temperatures and all genetic and molecular manipulations followed standard 
published protocols (Adams et al., 1997). 
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3.2.2 mRNA isolation and analysis 
A single yeast colony was inoculated into 2 ml of YPD incubated over night at 30° C with 
vigorous shaking. The culture was diluted into 10 ml of YPD (pH 5.4) to an OD (optical density 
measured at 600 nm) of 0.25 and grown for 4 h at 30°C with vigorous shaking to obtain mid-log 
phase cells.  Ten ODs of cells were harvested and resuspended in YPD adjusted to pH 5.4 and 
supplemented either with or without 2 mM DTT and incubated at 30° C with vigorous shaking 
for 2 h.  A total of 5 ODs of cells were harvested by centrifugation at 3000 rpm for 5 min in a 
clinical centrifuge.  Cells were then resuspended in 0.2 ml of RNA buffer ((0.5 M NaCl, 0.2 M 
Tris-HCL (pH 7.6), 1.0% SDS).  A total of 0.2 g of glass beads were added, and lystates were 
prepared by vigorous agitation on a Vortex mixer five times for one min with a one min 
incubation in an ice bath between each treatment.  Total RNA was isolated utilizing the RNeasy 
Mini kit (Qiagen) in conjunction with the standard protocol provided by the manufacturer.  RNA 
concentration and purity were determined spectrophotometrically by measuring the A
260 
and 
A
280
. Only samples with a ratio of A
260
/A
280 
higher than 1.8 were used.  Aliquots of all RNA 
samples were frozen and stored at -20°C.   
Reverse transcription (RT) was conducted by utilizing random primers (Hexanucleotide 
Mix (Roche)), dNTP mix (Applied Biosystems), and the company-supplied protocol for the 
Super Script II Reverse Transcriptase (Invitrogen) kit with the following thermacyclic protocol: 
1 cycle of 25 C° for 10 min, 37 C° for 1 hr, 72 C° for 10 min, 23 C° for 10 min and finally stored 
at 4 C°.  Subsequent PCR reactions were performed to examine actin and ADD66 mRNA levels 
in accordance with the GoTaq PCR Kit (Promega) protocol.  ADD66 mRNA was amplified with 
5’ CGC TAT ATA AAG ACG CTG 3’ and 5’ GAA TAT ACC TCC TGT GGA CG 3’ primers 
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and actin was amplified with 5’ TGT CAC CAA CTG CGA CGA TA 3’ and 5’ GGC TTG GAT 
GGA AAC GTA GA3’ primers with the following PCR protocol:  1cycle of 94 C° for 2 min,  30 
cycles  of 94 C° for 1 min, 45 C° for 1 min, 72 C° for 1 min, 1 cycle  of 72 C° for 10 min, and 
finally store at 4 C°.  PCR products were resolved on a 1.0% agarose gel, stained with 2 μg/ml 
ethidium bromide, and images were obtained on a Kodak 440CF Image Station, and the results 
were quantified using Kodak 1D (version 3.6) imaging software. 
3.3 RESULTS 
3.3.1 Identification of a UPRE like sequence within the promoter of ADD66 
Examining targets of the unfolded protein response as well as their induction level revealed a 
robust increase in the level of ADD66 mRNA when cells were treated with ER stress inducing 
compounds (Casagrande et al., 2000; Travers et al., 2000).  Specifically, there was a 9.8 fold 
increase in ADD66 mRNA levels in cells treated with tunicamycin to inhibit N-linked 
glycosylation (Travers et al., 2000).  Expression of mouse major histocompatability complex 
class I heavy chain (H-2Kb), an ERAD substrate when unassembled but stable when the UPR is 
compromised, increased ADD66 mRNA 2.5-fold (Casagrande et al., 2000).  Taken together, 
ADD66 apears to be a bona fide UPR target, although examination of the 5’ UTR of ADD66 
failed to detect a UPRE (Travers et al., 2000).  One caveat of that initial search was that only 
previously described UPRE sequences (as observed in KAR2) were sought.  The original 22-bp 
UPRE sequence has subsequently been reduced to an essential seven nucleotide E-box-like 
palindrome (CAGNGTG) (Mori et al., 1992; Mori et al., 1998), which again was not detected 
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upstream of ADD66, at least in the region between ADD66 and LOS1 (Figure 34A).  However, 
expansion of the search criteria yielded a putative ADD66 UPRE 284 bps upstream of the coding 
region of ADD66 and residing in the correct orientation to induce ADD66 expression.  
Interestingly, this putative UPRE is located within the coding region of the neighboring gene, 
LOS1.  LOS1 is a nonessential tRNA alternate splicing enzyme located 249 base pairs upstream 
of ADD66 (Yoshihisa et al., 2003).  The putative ADD66 UPRE maintains 6 of the 7 essential 
nucleotides described as the E-box-like palindrome (Figure 34B).  Furthermore, comparisons of 
this region of DNA in three other yeast strains show a conservation of these nucleotides, 
suggesting an important function for this sequence (Figure 34B). 
3.3.2 The ADD66 UPRE is necessary for ADD66 mRNA induction during ER stress 
Given the similarity of the ADD66 UPRE to the KAR2 UPRE, and given that this sequence is 
conserved within different yeast specieis, I predict that this putative UPRE sequence would be 
required to provide maximal induction of ADD66 during the unfolded protein response.  In order 
to examine this hypothesis, a series of yeast strains were constructed or obtained from other 
sources (Figure 35).  The add66Δ and los1Δ  strains in the BY4742 background were constructed 
by disrupting the desired gene with a KANMX cassette (Brachmann et al., 1998).  The final two 
isogenic strains, in the W303-1A strain background, were obtained from the Endo lab, which 
included a wild type as well as a second los1Δ strain.  The second los1Δ strain had the majority 
of the LOS1 gene disrupted, by an ADE2 cassette, but retained the region that contained the 
putative ADD66 UPRE (Figure 35A MT3) (Yoshihisa et al., 2003).   
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Figure 34.  The ADD66 promoter contains a UPRE-like sequence and is conserved in four 
different Saccharomyces species 
(A)  A simple diagram of the chromosomal locations of the putative ADD66 UPRE (red) 
in relation to the coding regions of the ADD66 (blue) and LOS1 (green) genes.  Arrows indicate 
the direction of transcription from ADD66 (Crick stand) and LOS1 (Watson strand).  (B) 
Nucleotide sequence alignment of the putative UPRE for ADD66 in four different yeast species 
compared to the KAR2 UPRE.  Sequences were obtained from the Saccharomyces Genome 
Database (http://www.yeastgenome.org/).  Bold type face shows identity with the KAR2 UPRE, 
which is 153-bp upstream of the KAR2 start site.  The putative ADD66 UPRE is 284-bp upstream 
of the start site and is in the correct orientation to induce ADD66 expression.  Red type face 
indicates the E-box-like palindrome.  Underline shows the core 10 base pair element.   
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 Figure 34.  The ADD66 promoter contains a UPRE-like sequence and is conserved in four different 
Saccharomyces species 
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Figure 35.  ADD66 strains used to examine UPR regulation 
(A) A diagram of the chromosomal locations of the putative ADD66 UPRE (red) in 
relation to the coding regions of the genomic ADD66 (blue) and LOS1 (green) genes.  The 
ADD66 (WT1; BY4742) strain is isogenic to add66Δ (MT1) and los1Δ (MT2) strains.  MT1 and 
MT2 are disruptions with the insertion of a KANMX gene (black).  The other ADD66 wild type 
(WT2; W303-1A) strain is isogenic to los1Δ (MT3) in which LOS1 is replaced with ADE2 (grey) 
while still maintaining the putative ADD66 UPRE.  All strains are described in Section 3.2.1 and 
in Table 2, located in Appendix A.  The ADD66, LOS1, KanMX, and ADE2 genes are presented 
in relative size to each other.  Asterisks denote the locations of primers utilized for the RT-PCR 
of ADD66, as presented in Figure 36.  (B)  PCR products corresponding to the regions of the 
ADD66 (left panel) and LOS1 (right panel) genes in the five strains indicated above.  Primers 
utilized for this PCR are detailed in section 3.2.1.  The sizes of the PCR products are shown to 
the left of the figure.  
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 Figure 35.  ADD66 strains used to examine UPR regulation 
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To examine ADD66 mRNA induction during ER stress, mid-log phase yeast cells were 
subjected to 2 mM DTT to increase the propensity of misfolded proteins within the ER (Travers 
et al., 2000). Cells under identical conditions were also mock-treated. Cells treated with DTT 
that contained the putative ADD66 UPRE showed an increase in the levels of ADD66 expression 
(Figure 36A, WT1, WT2, and MT3).  As predicted, strains that did not contain putative ADD66 
UPRE maintained basal levels of mRNA induction when treated with DTT (Figure 36A, MT2).  
Furthermore, there was a significant difference between the level of ADD66 mRNA induction 
when comparing the two different yeast genotypes.  The BY4742 ADD66 strain incubated with 
DTT showed a 2.3 fold increase in expression of ADD66 mRNA compared to non-treated cells, 
whereas the W303-1A strain exhibited a 7.9 fold increase.  Taken together, these very 
preliminary data suggest that the region containing the putative ADD66 UPRE is necessary for 
transcriptional induction during the unfolded protein response. 
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 Figure 36.  The ADD66 UPRE facilitates ADD66 mRNA induction during ER stress 
RT-PCR was performed on the ADD66 (BY4742; WT1), add66Δ (BY4742; MT1), los1Δ 
(BY4742; MT2), ADD66 (W303-1A; WT2), and los1Δ (W303-1A; MT3) strains.  (A)  Relative 
fold increase of ADD66 mRNA expression when cells were incubated with 2mM DTT (black 
bars) or the equivalent volume of water (white bars) for 2 hours at 30° C.  The RT-PCR product 
was obtained by amplifying an internal region of the ADD66 gene (Figure 35, asterisks).  
Quantification of each PCR product was determined by measuring the intensities of the various 
products, and then normalizing these values to the levels measured for the actin RT-PCR 
product.  The relative fold increase was subsequently determined by normalizing each RT-PCR 
product to the product from the untreated isogenic WT strain, which was set to 1.  (B)  The 
agarose gels used to amass the data for part A are presented.   Each strain was treated with (+) or 
without (-) DTT as indicated.  It is important to note that these data represent one experiment 
utilizing one set of PCR parameters.  In addition, the mRNA might not be within the linear range 
for the assay. 
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 Figure 36.  The ADD66 UPRE facilitates ADD66 mRNA induction during ER stress 
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4.0  DISCUSSION 
4.1 INTRODUCTION 
In this chapter I will revisit the data presented in this dissertation from chapters two and three 
and discuss the significance and relevance of these findings.  Furthermore, I will present these 
findings in the context of what is currently known about proteasome assembly, maturation, and 
activity and the regulation of ADD66 during the unfolded protein response. 
4.2 ADD66 IS REQUIRED FOR MAXIMAL CHYMOTRYPSIN-LIKE ACTIVITY OF 
THE 26S PROTEASOME 
In this dissertation I presented the characterization of Add66p (Chapter 2), a protein previously 
implicated in the ERAD of A1PiZ in yeast (Palmer et al., 2003). I found that strains deleted for 
ADD66 accumulate polyubiquitinated proteins and grow poorly when they are unable to mount a 
UPR upon being challenged with a UPR-inducing agent.  These data can be explained by my 
discovery that the CTL activity of the proteasome is compromised in add66Δ yeast.  Yeast 
deleted for ADD66 also accumulate the similar proteasome assembly intermediates as those 
observed when the gene encoding the Ump1p proteasome assembly factor is disabled.  My 
observations are consistent with the fact that Add66p is found in a multi-protein complex that 
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includes Pre1p and Pre5p—proteins embedded within the 20S core particle—as well as Ump1p 
itself (Ho et al., 2002; Krogan et al., 2006). Based on these data, I propose that Add66p is a yeast 
proteasome assembly chaperone (PAC, discussed below) and is vital for maximal proteasome 
function. 
A surprising aspect of this research was that deletion of ADD66 appeared to affect the 
CTL activity of the 26S proteasome, whereas there were no obvious defects in the TL and PGPH 
activities.  This is in contrast to the fact that all three activities are decreased in an ump1Δ strain 
(Ramos et al., 1998).  I propose two explanations for this phenomenon.  First, Ump1p may have 
a global effect on proteasome activity due to its role as an assembly checkpoint during the 
dimerization of half proteasomes (Li et al., 2007).  Thus, deletion of UMP1 may result in a 
significant accumulation of defective dimers or other intermediates, thus reducing the level of 
functional 26S proteasomes.  In contrast, the Add66p-dependence during proteasome maturation 
may give rise to subtle changes in proteasome assembly or even in the conformations of 
individual, catalytic subunits or associated subunits.  Consistent with this model, more severe 
proteasome assembly defects were noted in ump1Δ versus add66Δ mutants when intermediates 
were resolved by gel filtration chromatography (Ramos et al., 1998; Li et al., 2007).  Second, 
more trivially, I note that neither the TL nor PGPH activities was measured when the activities of 
specific proteasome assembly factors were ablated (Tone and Toh, 2002; Hirano et al., 2005; 
Hirano et al., 2006).  Therefore, it remains possible that unique effects on proteolytic activities 
do exist when related PACs are disabled, at least in some cell types or under specific conditions. 
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4.3 ADD66P FACILITATES EFFICIENT PROTEASOME ASSEMBLY 
 
The recent characterization of PACs in both yeast and mammals have yielded new insights into 
the previously described pathway of proteasome biogenesis (Chen and Hochstrasser, 1995, 1996; 
Heinemeyer et al., 1997; Ramos et al., 1998; Arendt and Hochstrasser, 1999; Burri et al., 2000; 
Griffin et al., 2000; Tone et al., 2000; Witt et al., 2000; Tone and Toh, 2002; Ramos et al., 2004; 
Hirano et al., 2005; Hirano et al., 2006; Li et al., 2007).  The symmetrical, 20S barrel-shaped 
core particle (CP) of the proteasome is comprised of two half-proteasome (15S) complexes 
(Nandi et al., 1997).  These half-proteasomes contain a ring of alpha subunits and a ring of beta 
subunits, three of which are responsible for the CP’s proteolytic activity and must be processed 
(Figure 3). In mammals, after the two 15S complexes combine, the “pro” regions in the beta 
subunits are cleaved and a cohort of PACs—including hUmp1 (also known as POMP or 
Proteassemblin), PAC1, PAC2, and PAC3—participate in complex formation.  PAC1 and PAC2 
have been proposed to maintain the assembly-competence of the alpha ring and are degraded 
after the assembly of the two half proteasomes; in contrast, PAC3 assists in the assembly of the 
beta ring before dissociating from the complex.  PAC3 also recruits hUmp1, which later 
catalyzes the dimerization of the two half-proteasomes; in yeast Nob1p helps glue the 19S 
particle to the CP (Tone and Toh, 2002; Hirano et al., 2005; Hirano et al., 2006).   Based on my 
results and data derived from studies of PAC2 function in mammalian cells (Hirano et al., 2005; 
Hirano et al., 2006), I propose that Add66p is the S. cerevisiae homologue of PAC2: [1] The 
proteins are ~20% identical throughout their sequence; [2] Both factors are proteasome 
substrates; [3] Lowering protein levels (by RNAi in mammalian cells) or completely ablating the 
gene (in yeast) leads to the accumulation of CP precursors, increases the concentration of 
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polyubiquitinated proteins,  and decreases the proteasome’s CTL activity; and [4] MG-132 
treatment in each cell-type results in the accumulation of the protein in heavier (larger 
complexes) fractions after glycerol gradient centrifugation.   
Very recent work from  Hochstrasser and colleagues reported that Add66p (which they 
named Pba2p, for proteasome biogenesis associated polypeptide) associates with another protein 
(Pba1p) to form a stable complex (Li et al., 2007); the Add66p-Pba1p complex resolves with 
distinct proteasome assembly intermediates and it was found that deletion of ADD66 restores the 
growth of an ump1Δ mutant, which is consistent with antagonistic action between Ump1 and the 
PACs.  They also reported that the concentration of a pro-β5 assembly intermediate increased in 
the add66Δ mutant, which is consistent with the intermediate I observe in add66Δ yeast (Figure 
26 and Figure 27).  Combined with the results reported here and with studies in mammalian cells 
(Hirano et al., 2005; Hirano et al., 2006), these data provide support that Pba1p and Add66p 
have similar functions as PAC1 and PAC2, respectively. 
4.4 ADD66P IS INVOLVED IN THE DEGRADATION OF A DISCRETE SET OF 
PROTEINS 
In contrast to other studies of PAC function in mammalian cells and yeast, I have determined the 
importance of Add66p on the degradation of a distinct class of proteins.  More specifically, I 
have discovered a link between PAC function and ERAD.  In previous work, the Brodsky and 
McCracken laboratories noted that Add66p facilitates the degradation of some ERAD substrates 
(A1PiZ and the cystic fibrosis transmembrane conductance regulator, CFTR) but not others 
(CPY* and pro-α factor) (Palmer et al., 2003).  At first glance, these data and the results 
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presented in this dissertation may seem at odds.  If the proteasome is partially disabled in add66 
mutants, why isn’t the turn-over of all ERAD substrates affected similarly, especially since any 
one of the proteasome’s three activities may be sufficient to remove an ERAD substrate 
(Oberdorf et al., 2001)?  Consistent with data from other laboratories, I suggest two possible 
answers to this question: 
First, I propose that the rate-limiting step during ERAD differs for unique classes of 
substrates.  Notably, ERAD can be envisaged as a five-step temporal and—for some substrates—
spatial process, consisting of substrate identification, retro-translocation, polyubiquitination, 
deubiquitination, and degradation (Figure 5).  In reality, each of these steps is likely further 
delineated into multiple, discrete kinetic events.  Regardless, the overall rate of substrate 
degradation, as for any multi-step process, is established by the rate-limiting step.  For the 
degradation of some substrates, it has been shown that de-ubiquitination is the rate-limiting step 
(Yao and Cohen, 2002; Guterman and Glickman, 2004; Hanna et al., 2006).  At present, the 
identity of the DUB that acts on A1PiZ and whether it is proteasome associated are unknown.  
During ERAD, the removal of a specific substrate class (proteins in the “ERAD-L” family) takes 
significantly longer than the removal of other substrates (proteins in the “ERAD-C” family).  
This may be because only ERAD-L substrates can transit to the Golgi apparatus prior to ER-
retrieval and degradation (Vashist et al., 2001).  Thus, effects arising from impaired proteasome 
function (Figure 19-22) might be masked by earlier steps in the ERAD process when they are 
acting as an alternative, rate-limiting step. 
Second, it has been proposed that proteasome isoforms exist within cells: those that are 
stable and those that recycle (Fujimuro et al., 1998; Tone and Toh, 2002).  In fact it was later 
reported that the proteasome disassembles after ATP hydrolysis and substrate degradation 
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(Babbitt et al., 2005).  Combined with the concept that specific proteasome sub-populations may 
recognize distinct classes of substrates (Fujimuro et al., 1998), it is possible that A1PiZ is 
degraded by only one of these “classes”.   Formally then, the deletion of ADD66 might 
compromise the assembly of a unique proteasome sub-set, which is required for the degradation 
of some but not all substrates.  Alternatively, the absence of Add66p might alter the 
proteasome’s interaction with the ER membrane.  Different ERAD substrates might be delivered 
from the ER in different conformations, only some of which may require close apposition of the 
proteasome with the ER and possibly Sec61p, which is the translocation and possibly the retro-
translocation channel (Kalies et al., 2005). 
4.5 RELATIONSHIP OF ADD66Δ YEAST EXPRESSING A1PIZ  
One of the long-term goals of my studies is to identify conserved yeast genes that impact the 
ERAD of distinct substrates.  This undertaking is particularly relevant for A1PiZ, given that only 
a small percentage of A1PiZ homozygotes develop severe liver disease (Sveger, 1988).  It is 
believed that both environmental and genetic modifiers play a role in determining the onset and 
severity of liver disease (Wu et al., 1994; Perlmutter, 2002).  Therefore, it is critical that genetic 
polymorphisms or secondary mutations that alter A1PiZ quality control are identified.  
Intriguingly, I found that ~15% of add66Δ cells expressing A1PiZ are inviable (data not shown, 
Figure 30 for one example).  In principle, one might be able to co-opt this phenotype to screen 
for second-site or suppressor mutations.  It is also possible that the observed genetic penetrance 
arises from stochastic variability in some cells relative to others: Recent insights into phenotypic 
variation have led to a greater understanding of the “noise” that accounts for the stochastic nature 
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of protein production and phenotypic variation, especially in single-cell organisms (Raser and 
O'Shea, 2004; Newman et al., 2006; Samoilov et al., 2006).     
Another explanation for why a sub-population of cells exhibit growth defects (and why a 
sub-population of individuals with ATD develop liver disease) is that alternate mechanisms exist 
to clear the ER of A1PiZ.  Indeed, it is now established that the autophagic pathway can degrade 
A1PiZ in mammalian cells (Teckman and Perlmutter, 2000; Kamimoto et al., 2006) and in yeast 
(Kruse et al., 2006) when the protein is over-expressed.  However, I found that the autophagic 
pathway is active in add66Δ cells (Figure 15), suggesting that variations in this alternate mode of 
protein quality control do not contribute to the toxic effects of A1PiZ, at least in yeast.  In the 
future, it will be important to measure how variations in the efficiency of autophagy, as well as 
variations in the relative steady-state levels of A1PiZ, impact A1PiZ clearance and liver disease 
in individuals afflicted with ATD. 
4.6 ROLE OF PAC2 IN A1PIZ CLEARANCE 
 
In Chapter 2, I showed that expression of Add66p is required for maximal proteasome activity in 
yeast, and previous studies have shown that Add66p facilitates the efficient degradation of 
A1PiZ (Palmer et al., 2003).  As noted above, I also propose that Add66p functions similarly to 
mammalian PAC2 (Hirano et al., 2005; Hirano et al., 2006; Li et al., 2007).  Neverless, these 
data do not address the fundamental question of whether PAC2 plays a role in the regulation of 
the mutant form of AT in mammalian tissues.  In collaboration with the Perlmutter lab, we 
observed that PAC2 over-expression enhances A1PiZ clearance in HeLa cells (Figure 33).  
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While these data are extremely encouraging, they are preliminary and difficult to interpret with a 
high level of confidence. Thus, further investigations will be necessary to determine if PAC2 
plays a significant role in the clearance of A1PiZ.  Specifically, all three proteolytic activities of 
the 26S proteasome in cells over-expressing PAC2 must be quantified and compared to control 
HeLa cells to determine if the over-expression of PAC2 induces higher rates of proteolytic 
activity.  Next, PAC2 knock-down, performed by RNAi as previously published (Hirano et al., 
2005), will need to be undertaken to examine the effects on A1PiZ solubility and stability.  
Finally, it would be interesting to determine if PAC2 decreases the accumulation of A1PiZ 
observed in the add66Δ yeast strain.   If the results from the experiments described above are 
positive, then we can conclude that PAC2 plays a role in the clearance of A1PiZ, perhaps in a 
manner similar to the one that Add66p plays during the degradation of A1PiZ in yeast (Palmer et 
al., 2003). 
4.7 REGULATION OF ADD66 DURING THE UNFOLDED PROTEIN RESPONSE 
It has been previously shown that ADD66 mRNA is induced robustly during to the unfolded 
protein response (Casagrande et al., 2000; Travers et al., 2000).  To begin characterizing the 
regulation of ADD66 during the UPR, two questions needed to be addressed: First is ADD66 
expression transcriptionally regulated by the transcription factor Hac1p, which is one of the two 
known transcription factors that up-regulates the 380 genes targeted by the UPR (Mori et al., 
1992; Cox and Walter, 1996; Sidrauski et al., 1996; Mori et al., 1998; Travers et al., 2000)?   
Second, does the ADD66 promoter contain a bona fide UPRE, which is a conserved sequence 
recognized by Hac1p (Mori et al., 1992; Mori et al., 1998)? 
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            A previous examination of the 5’ UTR of ADD66 did not reveal a UPRE (Mori et al., 
1992; Mori et al., 1998; Travers et al., 2000).  However, I have expanded the search and 
identified a putative ADD66 UPRE, which is located in the correct orientation for proper 
transcriptional regulation of ADD66 (Figure 34A).  The putative ADD66 UPRE maintains 6 of 
the 7 essential nucleotides described as the E-box-like palindrome (Figure 34B).  Furthermore, 
preliminary data suggest that the region containing the putative ADD66 UPRE is required for 
maximal induction of ADD66 mRNA during the UPR (Figure 36).   
As stated, these data are preliminary and require further investigations, because only one 
assay was performed.  Replicates should be carried out to determine the significance of the data.  
Next, it was shown previously that yeast cells treated with 2mM DTT produced a 9-fold 
induction of ADD66 mRNA expression (Travers et al., 2000), while I observed only 2- or 5-fold 
induction (Figure 36A, BY4724 or W303-1A yeast strains respectively).  While the parameters 
to induce ER stress in the yeast cells were similar to previously published methods, the detection 
of mRNA induction was different.  While I performed RT-PCR, the previous study utilized 
microarray analysis, which could possibly account for the variability I observed (Travers et al., 
2000).  Finally, it is unknown whether the RT-PCR assay I performed was within the linear 
range of the assay, which is essential to accurately measure mRNA induction.  Thus, the 
decreased mRNA induction I observed in my initial assay may be masking a true, higher level of 
induction.  It should be noted that in parallel with the ADD66 induction studies, KAR2, a known 
UPR target, induction was also examined, and no significant increase of expression was 
observed (data not shown) (Mori et al., 1992; Cox et al., 1993; Mori et al., 1998; Patil et al., 
2004).  I hypothesize that the lack of KAR2 induction, which is basally produced at abundant 
levels (13.6 copies of KAR2 mRNA per cell versus 0.8 copies of ADD66 mRNA per cell 
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(http://web.wi.mit.edu/young/expression/transcriptome2.html), was not detectable via RT-PCR 
during ER stress, because the substrate was already saturating the system.  Thus, further assays 
will need to be conducted, varying the RT-PCR conditions.  Furthermore, real time PCR can be 
employed to complement this assay.  Finally, the deletion of ADD66 caused sufficient ER stress 
to induce the UPR, as detected by an in vitro β-Galactosidase reporter assay (Palmer et al., 
2003).  Therefore, I predict that the putative ADD66 UPRE, cloned as a UAS into the reporter 
plasmid, would be sufficient to report ER stress.  These experiments will be performed in the 
future. 
To induce the UPR, Hac1p binds to the target gene’s UPRE (Patil and Walter, 2001; 
Schroder and Kaufman, 2005).  Currently, it is unclear if transcriptional regulation of ADD66 is 
conducted by Hac1p.  However, the idea of ADD66 transcriptional regulation by Hac1p is 
supported by the identification of a putative UPRE.  To examine if Hac1p binds upstream of 
ADD66, electrophoretic mobility shift assays (EMSA) will need to be conducted on DNA 
isolated from yeast strains, under conditions that promote ER stress, containing or lacking the 
ADD66 UPRE.  It is predicted that the sequence containing the putative ADD66 UPRE is 
sufficient to bind Hac1p when these strains are grown in conditions that induce the UPR.  The 
EMSA assay results will be complimented with a chromatin immunoprecipitation (CHIP) assay 
to verify Hac1p association with the putative ADD66 UPRE in vivo.  These two assays will be 
performed in the future. 
4.8 POSSIBLE FUTURE DIRECTIONS OF RESEARCH CONCERNING ADD66P 
Beyond the experiments detailed above concerning the regulation of ADD66 during UPR 
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induction, future work should be conducted concerning Add66p’s role in proteasome assembly 
and activity.  The eukaryotic proteasome is one of the most complex ring shaped 
macromolecules, and future efforts must focus on the resolution of pre-half proteasome 
complexes.  The isolation of these initial proteasome assembly intermediates and subsequent 
analysis with tandem mass spectrometry will allow better insights how the proteasome subunits 
associate with the various PACs, i.e. Add66p, as well as the order of events regarding of subunit 
assembly.  Furthermore, this line of investigation may also isolate yet unidentified PACs. 
. 
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APPENDIX A 
YEAST STRAINS USED IN THIS STUDY 
Table 2. Yeast strains used in this study 
Strain Relevant Genotype Reference 
ADD66 
(BY4742) 
MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 Invitrogen 
add66Δ MATα add66::kanMX  his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 Invitrogen 
ire1Δ MATα ire1::kanMX his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 Invitrogen 
ire1Δ add66Δ MATα ire1::kanMX add66::HIS3 his3Δ1 leu2Δ0 
lys2Δ0 ura3Δ0 
this study 
ADD66 (W303) MATa ade2-1 can1-100 his3-11,15 leu2-3,112 trp1-1, 
urs3-1 
 
add66Δ MATa add66::kanMX ade2-1 can1-100 his3-11,15    
leu2-3,112 trp1-1, ura3-1 
this study 
CIM5 MATα ura3-52 lys2-801 ade2-101 his3Δ200 leu2- Δ1 Ghislain et al, 1993 
cim5-1 MATa cim5-1 ura3-52 his3Δ0200 leu2- Δ1 Ghislain et al, 1993 
atg14Δ MATα atg14::kanMX his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 Invitrogen 
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pdr5Δ MATa pdr5::kanMX his3Δ1 leu2Δ0 ura3Δ0 lys2Δ0 
met15Δ0 
this study 
JD133 MATa his3-Δ200 leu2-3,112 lys2-801 trp1-Δ63 ura3-
52 UMP1-ha::YIplac128 PRE2-HA::YIplac211 
Ramos et al., 1998 
JD134 MATa his3-Δ200 leu2-3,112 lys2-801 trp1-Δ63 ura3-
52 ump1-Δ1::HIS3 PRE2-HA::YIplac211 
Ramos et al., 1998 
add66Δ MATα add66::kanMX  his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 Invitrogen 
add37Δ MATα add37::kanMX  his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 Invitrogen 
add67Δ MATα add67::kanMX  his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 Invitrogen 
add68Δ MATα add68::kanMX  his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 Invitrogen 
add66Δ MATα add66::kanMX  his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 Invitrogen 
los1Δ MATα los1::kanMX  his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 Invitrogen 
RJD1144 MATa his3Δ200 leu2-3,112 lys2-801 trp1Δ63 ura3-
52 PRE1-Flag-HIS6::Ylpac211 (URA3) 
Vera et al., 2000 
W303-1A MATa ura3-1, leu2-1, trp 1-1, his3-11, can1-100 
ADE2  
Yoshihisa, 2003  
TYSC188 MATa ura3-1, leu2-1, trp 1-1, his3-11, can1-100 
ADE2 los1::URA3 (W303-1A) 
Yoshihisa, 2003  
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APPENDIX B 
HEAT SHOCK PROTEIN (HSP101) EXPRESSION IN ARABIDOPSIS THALIANA 
UNDER CONTROLLED THERMAL CONDITIONS 
B.1 INTRODUCTION 
Global warming as well as climate shifts have presented a unique ecological situation in regards 
to plant tolerance and fitness.  The ability or the inability to adapt to various and sudden 
temperature shifts can result in a decrease in an individual’s or species’ fitness as well as 
biodiversity in a natural community of plants.  Previous examination of plant thermal tolerance, 
specifically crop plants, demonstrated a decrease in corn crop yield when the plants experienced 
a temperature increase during the growing seasons (Lobell and Asner, 2003).  High temperature 
affects organisms by causing membrane integrity loss, protein inactivation and denaturation, and 
metabolic and cellular disequilibrium, which may ultimately lead to cellular death (Quinn, 1988; 
Lindquist, 1992; Los and Murata, 2000).  However, most plant species have an innate capacity to 
survive high temperature stress and can sense and acclimate to high temperatures with metabolic 
and cellular adjustments.  This allows some level of tolerance to heat extremes that would 
otherwise be lethal.  This process is known as  acquired thermal tolerance (Vierling, 1991).    
Heat shock proteins (HSPs) are a type of molecular chaperone that reduces protein 
 159 
denaturation and aggregation, targets denatured proteins for proteasome degradation, and 
facilitates protein folding necessary for proper maturation (Johnson and Craig, 1997; Lee and 
Vierling, 2000; Frydman, 2001).  Plant HSPs lessen high temperature stress by allowing some 
level of thermal protein protection  (Vierling, 1991).   
The Tonsor lab wished to examine the naturally occurring genetic variation in expression 
of heat shock protein 101 (HSP101), in Arabidopsis thaliana.  Arabidopsis thaliana, commonly 
called arabidopsis, thale or mouse-ear cress, is a small flowering plant related to cabbage and 
mustard.  HSP101 has been shown previously to be a component of acquired thermal tolerance in 
Arabidopsis thaliana (Queitsch et al., 2000).  In other eukaryotes, members of this class of 
proteins are involved in thermal tolerance and repairing aggregated proteins (Sanchez and 
Lindquist, 1990; Sanchez et al., 1992; Parsell et al., 1994; Lindquist et al., 1995; Glover and 
Lindquist, 1998).  Over the past decade, there has been significant research in the role of HSPs as 
capacitors of variation (Queitsch et al., 2002; Maresca and Schwartz, 2006), but there is little 
known about variations of HSP101 expression and the effects of these variations.  Therefore, in 
collaboration with the Tonsor lab, I examined nine different Arabidopsis thaliana ecotypes to 
quantify their HSP101 expression levels grown at various temperatures.   
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 B.2 MATERIALS AND METHODS 
 
B.2.1 HSP101 Isolation, expression, and quantification 
The experiment consisted of four replicate arrays, and the following protocols were performed 
by Imene Boumaza, Toby Liss, and Steve Tonsor.  Each array contained three replicate plants of 
each genotype. Labeling was blind and location within an array was random. Plants were grown 
in Ray Leach SC10 “Supercell Conetainer” 164 ml. plastic pots 
(http://www.stuewe.com/products/rayleach.html) filled with Turface (www.turface.com) growth 
medium.  After five days at 4 ºC (to break dormancy) ,  racks of 21 Supercell Conetainers were 
placed in fiberglass trays and watered with an automatic ebb-and-flood system in which nutrients 
were supplied with Dosatron apportioners at a rate that maximized plant growth (Tonsor, 
unpublished).  Plants were grown in two Conviron PGW36 chambers retrofitted with automatic 
mist and watering controls. Light was supplied at 270 μMoles photons m-2s-1 for 16 hrs/24 hour 
period.  Temperatures cycled between 15 and 22 ºC night/day.  Two thermal treatments were 
imposed.  The control treatment was maintained as described above.  An HSP induction 
treatment was imposed by moving one array containing three replicates of each genotype from 
each of the control chambers to a third chamber for 2-3 hours every Monday, Wednesday and 
Friday between 11:00 and 15:00.  This third chamber had identical conditions to the control 
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chambers, except that temperature was maintained at 38 ºC.  After the ~2-hour induction 
treatment, all plants were returned to the control treatment chambers.   Locations of the control 
and induction replicate trays were switched within control chambers following each induction 
treatment to minimize location effects within the control chamber.  However, individual plants 
were consistently given either the control treatment or the periodic HSP induction treatment.   
At day 21, a single leaf was removed from each plant and total protein extract was 
obtained and clarified utilizing a previously established protocol (Hong and Vierling 2001).  I 
then assayed Hsp101 content was by western blot analysis.  In brief, 5 μg of total protein of each 
sample was resolved by SDS-PAGE and transferred onto nitrocellulose.  Hsp101 and GAPDH 
(glyceraldehyde-3-phosphate dehydrogenase), a component of the glycolytic pathway, were 
identified by western blotting using anti-Hsp101 and anti-GAPDH.  Western blots were 
developed using Enhanced Chemiluminescence (Pierce) according to the manufacturer’s 
instructions.  Images were obtained on a Kodak 440CF Image Station.  The results were 
quantified using Kodak 1D (version 3.6) imaging software, normalizing the level of Hsp101 
expression to the background as well as to GAPDH levels.   
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 B.3 RESULTS 
B.3.1 Temperature-response curve slopes differ genetically among natural populations 
across an induction temperature gradient 
A previous study demonstrated that HSP101 is a component of acquired thermal tolerance in 
Arabidopsis thaliana (Queitsch et al., 2000).   However, this study did not account for genetic 
variation of the Arabidopsis ecotypes located throughout the world, which could affect HSP101 
expression as a result of evolutionary pressures, such as acquired thermal tolerance.  Therefore, 
the Tonsor lab collected nine representative Arabidopsis species and subjected them to brief and 
various temperatures.  Next, leaves were collected from these plants (Table 3).  The Tonsor lab 
isolated cellular extracts from the different ecotypes, which I subsequently used to examine and 
quantify the level of HSP101 expression by immunoblotting techniques (Figure 37).  The 
HSP101 levels of these various ecotypes showed very little variation of protein expression at 
lower temperatures (22-34° C).  However, HSP101 protein levels showed significant variability 
in the different ecotypes when grown at 40° C.  Particularly, PHW-24 and Loch Ness, the two 
ecotypes examined in this study that resided at the most northern latitude, showed the greatest 
induction of HSP101 when heat shocked to 40° C. 
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 Table 3. Arabidopsis thaliana species utilized in this study 
Northern latitude (lat) and longitude (lon) (negative sign indicates West, positive East) 
are given.  “Accession” names are those used in the www.arabidopsis.org stock list. 
Accession  
Common 
Name 
Country Town/Source Lat Lon 
Altitude 
(m) 
Col Columbia Poland Landsberg/Warthe 53 16 100 
Sha Shakdara  Tadjikistan Pamiro-Alay 38 68 3400 
Mt Martuba Libya Martuba/Cyrenaika 33 23 312 
Ct Catania  Italy Catania, Sicily 37 15 100 
Lc Loch Ness  Scotland Loch Ness 58 -5 100 
Bay Bayreuth  Germany Bayreuth 49 16.5 150 
Est Estland  Russia Estland 59 28 200 
Co Coimbra  Portugal Coimbra 41 -9 100 
PHW-24 N/A United Kingdom Sidmouth 51 -3 10 
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Figure 37.  HSP101 induction due to temperature variation in nine different Arabidopsis 
thaliana ecotypes.   
Leaves from nine different wild type Arabidopsis thaliana ecotypes ((Bayreuth ; Bay, 
Columbia ; Col, Coimbra ; Co, Estland ; Est, Loch Ness ; LC, Martuba; Mt, No common name; 
PHW-24, Shakdara ; Sha, Catania ; Ct) see Table 3) were collected after heat induction at 
various temperatures (22, 28, 34, and 40°C).  Proteins in the leaf cellular extracts were resolved 
by SDS-PAGE and quantitative western blots were performed to detect the protein levels of 
HSP101 and GAPDH (as a loading control).  (A) Relative protein levels were determined by 
quantifying the intensities of HSP101 expression, and then normalizing these values to the levels 
GAPDH expression. Data represents the means of 9 independent experiments.  (B) A 
representative western blot used to amass the data in part A.  The samples resolved in the three 
lanes for each temperature are three random ecotypes assayed in this study. 
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 Figure 37.  HSP101 induction due to temperature variation in nine different Arabidopsis thaliana 
ecotypes 
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B.4 DISCUSSION 
During cellular stress, such as seen during growth at relatively non-permissive temperatures, for 
a given species there is an increased propensity of proteins to denature, misfold, or aggregate 
(Johnson and Craig, 1997; Brodsky and McCracken, 1999; Fewell et al., 2001; Frydman, 2001; 
Cristofari and Darlix, 2002; Nishikawa et al., 2005; Schroder and Kaufman, 2005).  
Furthermore, prolonged exposure to these stress-inducing conditions may ultimately lead to cell 
death.  Thus one must have a series of adaptive processes to prevent an untimely demise.  One of 
these processes is HSP induction, which is a significant response to alleviate the negative results 
of thermal stress (Johnson and Craig, 1997; Lee and Vierling, 2000; Frydman, 2001).  As noted 
earlier, HSP101 is a component of acquired thermal tolerance in Arabidopsis thaliana (Queitsch 
et al., 2000).  If HSP101 expression is beneficial, it suggests that this protein, as well as other 
proteins in the HSP family, would be s trongly and constitutively expressed regardless of the 
thermal conditions the plant might encounter.  However, examination of the nine ecotypes of 
Arabidopsis shows that the induction response varies widely in this species, both in the 
maximum amount of HSP101 expression in this experiment, as well as in the sensitivity to 
various temperature triggers (Figure 37).  These observations lead to two questions; why is 
HSP101 induced during times of thermal stress and not as strongly at other times, and why is 
there variation of HSP101 expression in the different ecotypes of Arabidopsis? 
To address the first question, there has been evidence suggesting that HSP expression is 
costly in both terms of energy and nitrogen use (Feder and Hofmann, 1999).  While the Tonsor 
lab demonstrated that the expression of the HSPs improves the amount of fruit in plants and thus 
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fitness when HSP is expressed (unpublished data), long-term expression of these molecular 
chaperones would ultimately reduce the fitness of the individual.  Thus, HSP101 is rapidly 
induced during times of thermal stress, but is not maintained for prolonged periods. 
To address the second question, we must consider the wide variations among the nine 
ecotypes of Arabidopsis in regards to the induction response at different temperatures.  The 
results suggest evolutionary adaptation.  Ecotypes such as PW-24 and Loch Ness, whose natural 
habitat is at the most northern latitude of those examined, exhibited the greatest induction of 
HSP101 at temperature greater than 38°C (Figure 37 and Table 3).  In contrast, ecotypes located 
closer to the equator, such as Catania and Martuba, showed a modest temperature-dependant 
increase in the level of HSP101 expression (Figure 37 and Table 3).  This suggests that the 
various ecotypes have adapted to their respective environments, at least with regard to thermal 
stress.  Northern ecotypes, which would have a lower mean temperature than those latitudes 
closer to the equator, would require a rapid response to sudden and dramatic tempature increases.  
Expression of HSP101 could accommodate the infrequent increase levels of denature, misfold, or 
aggregated proteins. Indeed data from studies on plant HSP101 homologues support this view.  It 
is unclear at this time what other adaptations these ecotypes might have acquired over time. 
These observations suggest further studies in the evolutionary adaptation of thermal 
tolerance and its variation in natural populations.  This will be invaluable in understanding the 
evolution of complex cellular stress responses and the cost-benefits of these responses in a 
varying environment.  Since agriculture output is strongly affected by thermal conditions, 
understanding the consequences of adapted thermal tolerance can be of considerable value for 
agriculture and man kind as a whole.   
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